| Title |
Publication Date |
Price |
CareFusion Medical Device Company Intelligence Report
|
February 2010 |
£295 |
Hill-Rom Medical Device Company Intelligence Report
|
February 2010 |
£295 |
Medtronic Medical Device Company Intelligence Report
|
February 2010 |
£295 |
Dentsply International Inc.-Therapeutic Competitors
|
January 2010 |
£230 |
Eli Lilly: Pipeline, Products,Performance,Potential
|
January 2010 |
£595 |
Instituto Bioclon S.A. de C.V.-Company Report
|
January 2010 |
£495 |
Insect Biotech Co., Ltd-Company Report
|
January 2010 |
£495 |
Inotek Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Intas Biopharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Intas Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Innopharmax, Inc.-Company Report
|
January 2010 |
£495 |
Intarcia Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Inimex Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Indoco Remedies Limited-Company Report
|
January 2010 |
£495 |
Indigene Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Indena S.p.A.-Company Report
|
January 2010 |
£495 |
Indukern Chemie AG-Company Report
|
January 2010 |
£495 |
Inflabloc Pharmaceuticals, Inc. (formerly Pharmadigm, Inc)-Company Report
|
January 2010 |
£495 |
Integrated BioTherapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Infugen Pharma Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Innocoll Inc.-Company Report
|
January 2010 |
£495 |
InterMed Discovery GmbH-Company Report
|
January 2010 |
£495 |
ItherX, Inc.-Company Report
|
January 2010 |
£495 |
Italfarmaco S.p.A-Company Report
|
January 2010 |
£495 |
Istituto Ganassini-Company Report
|
January 2010 |
£495 |
Izun Pharma Ltd-Company Report
|
January 2010 |
£495 |
J.B.CHEMICALS & PHARMACEUTICALS LIMITED-Company Report
|
January 2010 |
£495 |
JINIS Biotechnology Corporation-Company Report
|
January 2010 |
£495 |
JCR Pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
JADO Technologies GmbH-Company Report
|
January 2010 |
£495 |
Ipsat Therapies Oy-Company Report
|
January 2010 |
£495 |
Ipca Laboratories Limited-Company Report
|
January 2010 |
£495 |
Intercept Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Intercell AG-Company Report
|
January 2010 |
£495 |
Ind-Swift Limited-Company Report
|
January 2010 |
£495 |
Intercytex-Company Report
|
January 2010 |
£495 |
Intra Labs Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Inviragen, Inc.-Company Report
|
January 2010 |
£495 |
Intra-Cellular Therapies, Inc. (ITI)-Company Report
|
January 2010 |
£495 |
Intendis GmBH-Company Report
|
January 2010 |
£495 |
InDex Pharmaceuticals AB-Company Report
|
January 2010 |
£495 |
Hope Pharmaceutical Inc.-Company Report
|
January 2010 |
£495 |
Hoe Pharmaceuticals Sdn. Bhd.-Company Report
|
January 2010 |
£495 |
Histogen, Inc.-Company Report
|
January 2010 |
£495 |
Hovid Bhd-Company Report
|
January 2010 |
£495 |
Humanetics Corporation-Company Report
|
January 2010 |
£495 |
Hybrigenics-Company Report
|
January 2010 |
£495 |
Hy BioPharma Inc.-Company Report
|
January 2010 |
£495 |
Hutchison China MediTech, Ltd-Company Report
|
January 2010 |
£495 |
Hisamitsu Pharmaceutical Co., Inc.-Company Report
|
January 2010 |
£495 |
Hikma Pharmaceuticals PLC-Company Report
|
January 2010 |
£495 |
Helix BioPharma Corp.-Company Report
|
January 2010 |
£495 |
Heidelberg Pharma AG-Company Report
|
January 2010 |
£495 |
Hebron-Company Report
|
January 2010 |
£495 |
Henan Topfond Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Heritage Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Highnoon Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Hetero drugs Ltd.-Company Report
|
January 2010 |
£495 |
Hydra Biosciences, Inc.-Company Report
|
January 2010 |
£495 |
Hyperion Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Immunotec Inc.-Company Report
|
January 2010 |
£495 |
ImmuPharma plc-Company Report
|
January 2010 |
£495 |
ImQuest Life Sciences-Company Report
|
January 2010 |
£495 |
Immunotope, Inc.-Company Report
|
January 2010 |
£495 |
Immuron (formerly Anadis, Ltd.)-Company Report
|
January 2010 |
£495 |
JN International Medical Corporation-Company Report
|
January 2010 |
£495 |
Immutep S.A.-Company Report
|
January 2010 |
£495 |
ImClone Systems Incorporated-Company Report
|
January 2010 |
£495 |
Il-Yang Pharm.-Company Report
|
January 2010 |
£495 |
IDEA AG-Company Report
|
January 2010 |
£495 |
IBSA Institut Biochimique SA-Company Report
|
January 2010 |
£495 |
Hyundai Pharm. CO., LTD.-Company Report
|
January 2010 |
£495 |
IRX Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
IS Pharma plc (formerly Maelor Pharmaceuticals Ltd.)-Company Report
|
January 2010 |
£495 |
ISU ABXIS Inc. (formerly PetaGen)-Company Report
|
January 2010 |
£495 |
ISDIN-Company Report
|
January 2010 |
£495 |
Incitive Ltd-Company Report
|
January 2010 |
£495 |
JSC Grindeks-Company Report
|
January 2010 |
£495 |
Kuhnil Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Krka, d. d.-Company Report
|
January 2010 |
£495 |
Krenitsky Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
KunWha Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kureha Corporation (formerly Kureha Chemical Industry Co., Ltd.)-Company Report
|
January 2010 |
£495 |
Kwizda Pharma GmbH-Company Report
|
January 2010 |
£495 |
Kwang-Dong Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Kuros Biosurgery AG-Company Report
|
January 2010 |
£495 |
Kowa Company, Ltd.-Company Report
|
January 2010 |
£495 |
Korea Vaccine Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kissei Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kinex Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Kilitch Drugs (India) Ltd.-Company Report
|
January 2010 |
£495 |
Kitasato Institute Research Center for Biologicals-Company Report
|
January 2010 |
£495 |
Kobayashi Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kopran Ltd.-Company Report
|
January 2010 |
£495 |
Kontest Chemicals Limited-Company Report
|
January 2010 |
£495 |
Kyorin Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kyosei Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Cytochroma Inc.-Company Report
|
January 2010 |
£495 |
CytoTools AG-Company Report
|
January 2010 |
£495 |
CytImmune Sciences, Inc.-Company Report
|
January 2010 |
£495 |
Cytokine PharmaSciences Inc.-Company Report
|
January 2010 |
£495 |
Cytopia Ltd.-Company Report
|
January 2010 |
£495 |
DAVA Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
D-Pharm Ltd-Company Report
|
January 2010 |
£495 |
iNova Pharmaceuticals (Australia) Pty Limited-Company Report
|
January 2010 |
£495 |
hameln group gmbh-Company Report
|
January 2010 |
£495 |
Kythera Biopharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Kyowa Hakko Kirin Co., Ltd. (formerly Kyowa Hakko Kogyo Co., Ltd.)-Company Report
|
January 2010 |
£495 |
Kyoto Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
Kyung Dong Pharma. Co., Ltd.-Company Report
|
January 2010 |
£495 |
Labima-Company Report
|
January 2010 |
£495 |
Laboratoire Innotech International-Company Report
|
January 2010 |
£495 |
Laborate Pharmaceuticals India Ltd-Company Report
|
January 2010 |
£495 |
Kiadis Pharma B.V.-Company Report
|
January 2010 |
£495 |
KeyNeurotek AG-Company Report
|
January 2010 |
£495 |
Jerini AG-Company Report
|
January 2010 |
£495 |
Jennerex Biotherapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Jenburkt Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Jiangsu Hengrui Medicine Co., Ltd.-Company Report
|
January 2010 |
£495 |
Jiangsu Lianshui Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Juste S.A.Q.F.-Company Report
|
January 2010 |
£495 |
Jiwa Bio-Pharm Holdings Limited-Company Report
|
January 2010 |
£495 |
Jin Yang Pharmaceutical Co. Ltd-Company Report
|
January 2010 |
£495 |
Jemo-pharm A/S-Company Report
|
January 2010 |
£495 |
Jelfa Pharmaceutical Company SA-Company Report
|
January 2010 |
£495 |
Jagsonpal Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Jadran Galenski laboratorij d.d. (JGL)-Company Report
|
January 2010 |
£495 |
Healthpoint, Ltd.-Company Report
|
January 2010 |
£495 |
Janssen Pharmaceutica N.V.-Company Report
|
January 2010 |
£495 |
Janssen-Cilag S.p.A.-Company Report
|
January 2010 |
£495 |
Jeil Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Japan Tobacco Inc.-Company Report
|
January 2010 |
£495 |
KAI Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
KAKEN PHARMACEUTICAL CO., LTD.-Company Report
|
January 2010 |
£495 |
Kedrion S.p.A-Company Report
|
January 2010 |
£495 |
Karo Bio AB-Company Report
|
January 2010 |
£495 |
Kamron Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Kee Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Kemin Industries, Inc.-Company Report
|
January 2010 |
£495 |
Kereos, Inc-Company Report
|
January 2010 |
£495 |
Kenta Biotech Ltd.-Company Report
|
January 2010 |
£495 |
Kamada Ltd.-Company Report
|
January 2010 |
£495 |
Kalypsys, Inc.-Company Report
|
January 2010 |
£495 |
KIPA Pharmacal Ltd-Company Report
|
January 2010 |
£495 |
KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED-Company Report
|
January 2010 |
£495 |
KAKETSUKEN-Company Report
|
January 2010 |
£495 |
KOBEC Pharmacals-Company Report
|
January 2010 |
£495 |
KUKJE PHARMA IND CO LTD-Company Report
|
January 2010 |
£495 |
KaloBios Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Kaire International (Canada) Ltd-Company Report
|
January 2010 |
£495 |
JSC Farmak International-Company Report
|
January 2010 |
£495 |
Hawon Pharmaceutical Corporation-Company Report
|
January 2010 |
£495 |
Microlabs Ltd.-Company Report
|
January 2010 |
£495 |
MicroBiotiX, Inc-Company Report
|
January 2010 |
£495 |
Meyer Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Mikasa Seiyaku Co., Ltd.-Company Report
|
January 2010 |
£495 |
Milan Laboratories (India) Private Limited-Company Report
|
January 2010 |
£495 |
Minapharm Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Mimetica-Company Report
|
January 2010 |
£495 |
Millennium Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Metabolic Solutions Development Co.-Company Report
|
January 2010 |
£495 |
Metabolex, Inc.-Company Report
|
January 2010 |
£495 |
Merckle Group-Company Report
|
January 2010 |
£495 |
Merck Serono S.A.-Company Report
|
January 2010 |
£495 |
Merck KGaA-Company Report
|
January 2010 |
£495 |
Merrimack Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Merrion Pharmaceuticals, Ltd.-Company Report
|
January 2010 |
£495 |
Mesoblast Limited-Company Report
|
January 2010 |
£495 |
Merz Pharma GmbH & Co. KGaA-Company Report
|
January 2010 |
£495 |
Minerva Pharmaceutical S.A.-Company Report
|
January 2010 |
£495 |
Mipharm SpA-Company Report
|
January 2010 |
£495 |
Morepen Laboratories Limited-Company Report
|
January 2010 |
£495 |
Moraceae Pharmaceuticals Pvt Ltd.-Company Report
|
January 2010 |
£495 |
MonoSol RX-Company Report
|
January 2010 |
£495 |
MorphoSys AG-Company Report
|
January 2010 |
£495 |
Morria Biopharmaceuticals Plc.-Company Report
|
January 2010 |
£495 |
Mundipharma K.K.-Company Report
|
January 2010 |
£495 |
Mundipharma International Limited-Company Report
|
January 2010 |
£495 |
Molteni Farmaceutici-Company Report
|
January 2010 |
£495 |
Molteni Dental-Company Report
|
January 2010 |
£495 |
Mitsubishi Tanabe Pharma Corporation-Company Report
|
January 2010 |
£495 |
Mission Pharmacal Company-Company Report
|
January 2010 |
£495 |
Mirna Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Moberg Derma AB-Company Report
|
January 2010 |
£495 |
Mochida Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Molecular Design International (MDI)-Company Report
|
January 2010 |
£495 |
MolMed S.p.A.-Company Report
|
January 2010 |
£495 |
Merck Frosst Canada Ltd.-Company Report
|
January 2010 |
£495 |
Mercian Corporation-Company Report
|
January 2010 |
£495 |
Medek Ltd-Company Report
|
January 2010 |
£495 |
Meda AB-Company Report
|
January 2010 |
£495 |
MedExGen Inc.-Company Report
|
January 2010 |
£495 |
Medestea Internazionale S.p.A.-Company Report
|
January 2010 |
£495 |
MediGene AG-Company Report
|
January 2010 |
£495 |
Medico Remedies Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Medico Labs Inc-Company Report
|
January 2010 |
£495 |
MediQuest Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Mebiopharm Co., Ltd.-Company Report
|
January 2010 |
£495 |
May & Baker Nigeria Plc-Company Report
|
January 2010 |
£495 |
Marillion Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Mapra Laboratories Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Maneesh Pharmaceuticals Private Ltd-Company Report
|
January 2010 |
£495 |
MarinEx Pharmaceuticals Pte Ltd-Company Report
|
January 2010 |
£495 |
Maruho Co., Ltd.-Company Report
|
January 2010 |
£495 |
MaxoCore Pharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
Maruishi Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Medigen Biotechnology Corp.-Company Report
|
January 2010 |
£495 |
Mediline Ltd.-Company Report
|
January 2010 |
£495 |
Memgen, LLC-Company Report
|
January 2010 |
£495 |
Melior Discovery, Inc.-Company Report
|
January 2010 |
£495 |
Meiji Seika Kaisha, Ltd.-Company Report
|
January 2010 |
£495 |
Menarini Group-Company Report
|
January 2010 |
£495 |
Mentor Corporation-Company Report
|
January 2010 |
£495 |
MerLion Pharmaceuticals Pte. Ltd-Company Report
|
January 2010 |
£495 |
Mepha AG-Company Report
|
January 2010 |
£495 |
Medreich Plc-Company Report
|
January 2010 |
£495 |
Medopharm-Company Report
|
January 2010 |
£495 |
Medinox, Inc.-Company Report
|
January 2010 |
£495 |
Medinova AG-Company Report
|
January 2010 |
£495 |
Medimport S.A. de C.V-Company Report
|
January 2010 |
£495 |
Mediolanum farmaceutici S.p.A-Company Report
|
January 2010 |
£495 |
Medison Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Medivir AB-Company Report
|
January 2010 |
£495 |
Medisyn Technologies, Inc.-Company Report
|
January 2010 |
£495 |
Mutabilis-Company Report
|
January 2010 |
£495 |
MycoLogics, Inc-Company Report
|
January 2010 |
£495 |
GlycoMimetics, Inc.-Company Report
|
January 2010 |
£495 |
Gloucester Pharmaceuticals-Company Report
|
January 2010 |
£495 |
GlobeImmune, Inc.-Company Report
|
January 2010 |
£495 |
Glycotex, Inc.-Company Report
|
January 2010 |
£495 |
Goldshield Group plc-Company Report
|
January 2010 |
£495 |
Grifols, S.A.-Company Report
|
January 2010 |
£495 |
Green Cross Corporation-Company Report
|
January 2010 |
£495 |
Graceway Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Glenwood, LLC-Company Report
|
January 2010 |
£495 |
GRUPO URIACH-Company Report
|
January 2010 |
£495 |
multimmune GmbH-Company Report
|
January 2010 |
£495 |
mondoBIOTECH group-Company Report
|
January 2010 |
£495 |
moksha8 Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
neuMirRx Corporation-Company Report
|
January 2010 |
£495 |
GLYCOTOPE GmbH-Company Report
|
January 2010 |
£495 |
GP Pharm-Company Report
|
January 2010 |
£495 |
GNI Ltd.-Company Report
|
January 2010 |
£495 |
Grunenthal GmbH-Company Report
|
January 2010 |
£495 |
Grupo Ferrer-Company Report
|
January 2010 |
£495 |
Hansa Medical AB-Company Report
|
January 2010 |
£495 |
Hanmi Pharmaceutical Company Limited-Company Report
|
January 2010 |
£495 |
Hangzhou Jiuyuan Gene Engineering Co. Ltd-Company Report
|
January 2010 |
£495 |
Hawaii Biotech, Inc.-Company Report
|
January 2010 |
£495 |
DAWA Limited-Company Report
|
January 2010 |
£495 |
Hayashibara Co., Ltd.-Company Report
|
January 2010 |
£495 |
Hawthorn Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Handok Pharmaceuticals Co., Ltd.-Company Report
|
January 2010 |
£495 |
HanAll Pharmaceutical-Company Report
|
January 2010 |
£495 |
HELSINN HEALTHCARE SA-Company Report
|
January 2010 |
£495 |
H-Phar SA-Company Report
|
January 2010 |
£495 |
Gufic BioSciences Ltd.-Company Report
|
January 2010 |
£495 |
HERMES Biosciences-Company Report
|
January 2010 |
£495 |
HOMEOFARM Sp. z o.o.-Company Report
|
January 2010 |
£495 |
Hamilton Laboratories-Company Report
|
January 2010 |
£495 |
HRA Pharma-Company Report
|
January 2010 |
£495 |
medac GmbH-Company Report
|
January 2010 |
£495 |
NextWave Pharmaceuticals-Company Report
|
January 2010 |
£495 |
NatImmune A/S-Company Report
|
January 2010 |
£495 |
Narhex Life Sciences Ltd-Company Report
|
January 2010 |
£495 |
Napp Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Natural F&P. Inc-Company Report
|
January 2010 |
£495 |
Navamedic ASA-Company Report
|
January 2010 |
£495 |
Nectar Lifesciences Ltd.-Company Report
|
January 2010 |
£495 |
Navana Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Napo Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Nanotherapeutics, Inc.-Company Report
|
January 2010 |
£495 |
NATCO PHARMA LIMITED-Company Report
|
January 2010 |
£495 |
MyungMoon Pharm Co. Ltd-Company Report
|
January 2010 |
£495 |
Mystic Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
NERVIANO MEDICAL SCIENCES S.r.l.-Company Report
|
January 2010 |
£495 |
Nanjing Lifenergy R&D Co., Ltd.-Company Report
|
January 2010 |
£495 |
NanoDel Technologies GmbH-Company Report
|
January 2010 |
£495 |
NanoBio Corporation-Company Report
|
January 2010 |
£495 |
Neon Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Neopharma-Company Report
|
January 2010 |
£495 |
Neuropharm Group plc-Company Report
|
January 2010 |
£495 |
Neuromed Pharmaceuticals Ltd. (formerly NeuroMed Technologies)-Company Report
|
January 2010 |
£495 |
NeuroSearch A/S-Company Report
|
January 2010 |
£495 |
Neurotech Pharmaceuticals-Company Report
|
January 2010 |
£495 |
NewLink Genetics Corporation-Company Report
|
January 2010 |
£495 |
NexGenix Pharmaceuticals Holdings, Inc.-Company Report
|
January 2010 |
£495 |
Newron Pharmaceuticals SpA-Company Report
|
January 2010 |
£495 |
NeuroNova AB-Company Report
|
January 2010 |
£495 |
NeuroDiscovery Ltd-Company Report
|
January 2010 |
£495 |
Nephron Pharmaceuticals Corporation-Company Report
|
January 2010 |
£495 |
Neovacs SA-Company Report
|
January 2010 |
£495 |
Neotropix, Inc.-Company Report
|
January 2010 |
£495 |
Nereus Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
NeurAxon, Inc.-Company Report
|
January 2010 |
£495 |
Neurim Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Neuren Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Hayat Pharmaceutical Industries (HPI)-Company Report
|
January 2010 |
£495 |
DMI BioSciences, Inc.-Company Report
|
January 2010 |
£495 |
Bio-Pharm, Inc.-Company Report
|
January 2010 |
£495 |
Bilim Pharmaceuticals-Company Report
|
January 2010 |
£495 |
BiPar Sciences, Inc.-Company Report
|
January 2010 |
£495 |
BioAlliance Pharma-Company Report
|
January 2010 |
£495 |
BioCancell Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
BioNumerik Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
BioLineRx, Ltd.-Company Report
|
January 2010 |
£495 |
BioInvent International AB-Company Report
|
January 2010 |
£495 |
BiOrion Technologies BV-Company Report
|
January 2010 |
£495 |
Bharat Serums And Vaccines Limited-Company Report
|
January 2010 |
£495 |
Benesis Corporation-Company Report
|
January 2010 |
£495 |
Belupo-Company Report
|
January 2010 |
£495 |
Beijing Zizhu Pharmaceutical Co.,Ltd-Company Report
|
January 2010 |
£495 |
Besins Healthcare SA-Company Report
|
January 2010 |
£495 |
BestoChem Formulations (I) Ltd-Company Report
|
January 2010 |
£495 |
Bharat Biotech International Limited-Company Report
|
January 2010 |
£495 |
Beximco Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
BioPartners GmbH-Company Report
|
January 2010 |
£495 |
BioPhausia AB-Company Report
|
January 2010 |
£495 |
Biomedica International-Company Report
|
January 2010 |
£495 |
Biological E. Ltd.-Company Report
|
January 2010 |
£495 |
Biolex Therapeutics-Company Report
|
January 2010 |
£495 |
Biomedica foscama-Company Report
|
January 2010 |
£495 |
Biomet Europe B.V.-Company Report
|
January 2010 |
£495 |
Bionor Immuno AS-Company Report
|
January 2010 |
£495 |
Bionomics Limited-Company Report
|
January 2010 |
£495 |
Biolab Farmaceutica-Company Report
|
January 2010 |
£495 |
Biofrontera AG-Company Report
|
January 2010 |
£495 |
BioXell S.p.A.-Company Report
|
January 2010 |
£495 |
BioVex Inc-Company Report
|
January 2010 |
£495 |
BioPro Pharmaceutical, Inc.-Company Report
|
January 2010 |
£495 |
Biocad-Company Report
|
January 2010 |
£495 |
Biochefa-Company Report
|
January 2010 |
£495 |
Biofarma Pharmaceutical Industry Co. Inc.-Company Report
|
January 2010 |
£495 |
Biocompatibles International plc-Company Report
|
January 2010 |
£495 |
Beijing SL Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Bedford Laboratories-Company Report
|
January 2010 |
£495 |
Germiphene Corporation-Company Report
|
January 2010 |
£495 |
Georen Pharmaceuticals (Pty) Ltd.-Company Report
|
January 2010 |
£495 |
Genovate Biotechnology Co., Ltd. (GBL)-Company Report
|
January 2010 |
£495 |
Gerolymatos-Company Report
|
January 2010 |
£495 |
Gerot Pharmazeutika-Company Report
|
January 2010 |
£495 |
Glades Pharmaceuticals LLC.-Company Report
|
January 2010 |
£495 |
Giuliani S.p.A-Company Report
|
January 2010 |
£495 |
Giaconda Limited-Company Report
|
January 2010 |
£495 |
Geno Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Genmab A/S-Company Report
|
January 2010 |
£495 |
Genesis Research & Development Corporation Limited-Company Report
|
January 2010 |
£495 |
Generics (UK) Limited-Company Report
|
January 2010 |
£495 |
General Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Genetix Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Genexine Co., Ltd.-Company Report
|
January 2010 |
£495 |
Genfit-Company Report
|
January 2010 |
£495 |
Genextra S.p.A.-Company Report
|
January 2010 |
£495 |
Gland Pharma Limited-Company Report
|
January 2010 |
£495 |
Glenmark Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
BOUTY-Company Report
|
January 2010 |
£495 |
BLIS Technologies Ltd-Company Report
|
January 2010 |
£495 |
BL&H Co., Ltd.-Company Report
|
January 2010 |
£495 |
BTG plc-Company Report
|
January 2010 |
£495 |
Beacon Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
Beckpharma Ltd.-Company Report
|
January 2010 |
£495 |
Beacons Pharmaceuticals Pte Ltd-Company Report
|
January 2010 |
£495 |
BIOTON S.A-Company Report
|
January 2010 |
£495 |
BIOMED Wytwornia Surowic i Szczepionek Sp. z o.o.-Company Report
|
January 2010 |
£495 |
BELCO PHARMA-Company Report
|
January 2010 |
£495 |
ATCO Laboratories Limited-Company Report
|
January 2010 |
£495 |
e-Therapeutics-Company Report
|
January 2010 |
£495 |
BETA DERMACEUTICALS, INC.-Company Report
|
January 2010 |
£495 |
BINEX Co., Ltd-Company Report
|
January 2010 |
£495 |
BIOFARM Sp. z o.o.-Company Report
|
January 2010 |
£495 |
BIOCODEX-Company Report
|
January 2010 |
£495 |
BiopolyMed Inc.-Company Report
|
January 2010 |
£495 |
Biosyntrx, Inc.-Company Report
|
January 2010 |
£495 |
Cangene Corporation-Company Report
|
January 2010 |
£495 |
Canderm Pharma Inc.-Company Report
|
January 2010 |
£495 |
Cancer Research Technology Ltd.-Company Report
|
January 2010 |
£495 |
Cannasat Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Canopus BioPharma, Inc.-Company Report
|
January 2010 |
£495 |
Cara Therapeutics Inc-Company Report
|
January 2010 |
£495 |
Capricorn Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Capellon Pharmaceuticals, Ltd.-Company Report
|
January 2010 |
£495 |
CanBas Co., Ltd.-Company Report
|
January 2010 |
£495 |
Can-Fite BioPharma, Ltd.-Company Report
|
January 2010 |
£495 |
CSL Limited-Company Report
|
January 2010 |
£495 |
CSC Pharmaceuticals Handels GmbH-Company Report
|
January 2010 |
£495 |
CORIA Laboratories, Ltd.-Company Report
|
January 2010 |
£495 |
Cachet Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Calando Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Camurus AB-Company Report
|
January 2010 |
£495 |
Cambridge Laboratories-Company Report
|
January 2010 |
£495 |
Cardax Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Cellerant Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Changzhou Siyao Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Changchun ChangSheng Gene Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Chakshu Research-Company Report
|
January 2010 |
£495 |
Charlesson LLC-Company Report
|
January 2010 |
£495 |
ChemoCentryx, Inc.-Company Report
|
January 2010 |
£495 |
Chiesi Farmaceutici S.p.A-Company Report
|
January 2010 |
£495 |
Chenho Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Cerep-Company Report
|
January 2010 |
£495 |
Ceregene, Inc-Company Report
|
January 2010 |
£495 |
Celon Pharma-Company Report
|
January 2010 |
£495 |
Cellzome AG-Company Report
|
January 2010 |
£495 |
Celltran Limited-Company Report
|
January 2010 |
£495 |
Cempra Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Cenomed BioSciences, LLC-Company Report
|
January 2010 |
£495 |
Centrix Pharmaceutical, Inc.-Company Report
|
January 2010 |
£495 |
Centaur Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
COOPER PHARMA-Company Report
|
January 2010 |
£495 |
CLL PHARMA-Company Report
|
January 2010 |
£495 |
Blue Note Pharmaceuticals, BV-Company Report
|
January 2010 |
£495 |
Blue Cross Laboratories, Ltd.-Company Report
|
January 2010 |
£495 |
Blairex Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Boca Pharmacal, Inc.-Company Report
|
January 2010 |
£495 |
Boehringer Ingelheim GmbH-Company Report
|
January 2010 |
£495 |
Bolder BioTechnology, Inc.-Company Report
|
January 2010 |
£495 |
Bohus BioTech AB-Company Report
|
January 2010 |
£495 |
Blaine Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Biovitrum AB-Company Report
|
January 2010 |
£495 |
Biotest AG-Company Report
|
January 2010 |
£495 |
Biotec Pharmacon ASA-Company Report
|
January 2010 |
£495 |
Biota Holdings Limited-Company Report
|
January 2010 |
£495 |
Biothera.-Company Report
|
January 2010 |
£495 |
Biotherapix SLU-Company Report
|
January 2010 |
£495 |
Biotron Limited-Company Report
|
January 2010 |
£495 |
Biotie Therapies Corp.-Company Report
|
January 2010 |
£495 |
Bone Medical Ltd-Company Report
|
January 2010 |
£495 |
Boram Pharm. Co., Ltd.-Company Report
|
January 2010 |
£495 |
C&O Pharmaceutical Technology (Holdings) Limited-Company Report
|
January 2010 |
£495 |
BurnsAdler Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Bukwang Pharmaceutical Company Limited-Company Report
|
January 2010 |
£495 |
CBio Limited-Company Report
|
January 2010 |
£495 |
CCL Pharmaceuticals-Company Report
|
January 2010 |
£495 |
CJ Corp.-Company Report
|
January 2010 |
£495 |
CHO-A Pharmaceutical Company-Company Report
|
January 2010 |
£495 |
Brookes Pharmaceutical Laboratories (Pakistan) Limited-Company Report
|
January 2010 |
£495 |
British Biologicals-Company Report
|
January 2010 |
£495 |
Braintree Laboratories Inc.-Company Report
|
January 2010 |
£495 |
Bosnalijek d.d.-Company Report
|
January 2010 |
£495 |
Boryung Pharmaceutical Company, Ltd.-Company Report
|
January 2010 |
£495 |
Bravo Healthcare Ltd.-Company Report
|
January 2010 |
£495 |
Breckenridge Pharmaceutical, Inc.-Company Report
|
January 2010 |
£495 |
Britannia Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Bridge BioResearch plc-Company Report
|
January 2010 |
£495 |
GeneraMedix Inc.-Company Report
|
January 2010 |
£495 |
GeneScience Pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
EKR Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
EGIS Pharmaceuticals PLC-Company Report
|
January 2010 |
£495 |
ECR Pharmaceuticals-Company Report
|
January 2010 |
£495 |
ELPEN Pharmaceutical Co. Inc.-Company Report
|
January 2010 |
£495 |
ELSaad Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
EOS S.p.A.-Company Report
|
January 2010 |
£495 |
ENT Technologies PTY LTD-Company Report
|
January 2010 |
£495 |
EMZOR Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
EBEWE Pharma Ges.m.b.H. Nfg.KG-Company Report
|
January 2010 |
£495 |
Dynogen Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Drogsan Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Dr. Kade Pharmazeutische Fabrik GmbH-Company Report
|
January 2010 |
£495 |
Dr. Fischer SA / NV-Company Report
|
January 2010 |
£495 |
Drug Houses of Australia (Asia) Pte. Ltd.-Company Report
|
January 2010 |
£495 |
Drugfield Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Dynapharm (M) Sdn. Bhd.-Company Report
|
January 2010 |
£495 |
DynPort Vaccine Company LLC-Company Report
|
January 2010 |
£495 |
ERYtech Pharma-Company Report
|
January 2010 |
£495 |
ESBATech AG-Company Report
|
January 2010 |
£495 |
Embil Pharmaceutical Co. Ltd.-Company Report
|
January 2010 |
£495 |
Elixir Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Elite Pharma Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Emcure Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
EnVivo Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Endocyte, Inc.-Company Report
|
January 2010 |
£495 |
Enanta Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Elder Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
EirGen Pharma Ltd.-Company Report
|
January 2010 |
£495 |
EastPharma, Ltd.-Company Report
|
January 2010 |
£495 |
East India Pharmaceutical Works Limited-Company Report
|
January 2010 |
£495 |
ESPEFA-Company Report
|
January 2010 |
£495 |
Ebiotec-Company Report
|
January 2010 |
£495 |
Efroze Chemical Industries (Pvt.) Ltd-Company Report
|
January 2010 |
£495 |
Egyptian Co. for Chemicals & Pharmaceuticals S.A.E. (ADWIA)-Company Report
|
January 2010 |
£495 |
Egalet a/s-Company Report
|
January 2010 |
£495 |
Dr. Falk Pharma GmbH-Company Report
|
January 2010 |
£495 |
Dong-A Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Daiichi Sankyo Company, Limited-Company Report
|
January 2010 |
£495 |
Daihan Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Dafra Pharma nv-Company Report
|
January 2010 |
£495 |
Dainippon Sumitomo Pharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Dawnrays Pharmaceutical (Holdings) Ltd.-Company Report
|
January 2010 |
£495 |
Deciphera Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Debiopharm Group-Company Report
|
January 2010 |
£495 |
DaySpring Pharma-Company Report
|
January 2010 |
£495 |
Daewoong Pharmaceutical Co. Ltd.-Company Report
|
January 2010 |
£495 |
Daewon Pharm. Co., Ltd.-Company Report
|
January 2010 |
£495 |
DNAVEC Corporation-Company Report
|
January 2010 |
£495 |
Mallinckrodt Inc.-Company Report
|
January 2010 |
£495 |
DHG Pharmaceutical Joint Stock Company (formerly Hau Giang Pharmaceutical Joint Stock Company)-Company Report
|
January 2010 |
£495 |
DOMAIN Therapeutics (formerly Faust Pharmaceuticals)-Company Report
|
January 2010 |
£495 |
DONG WHA PHARM. IND. CO., LTD.-Company Report
|
January 2010 |
£495 |
Daehwa Pharm Co., Ltd.-Company Report
|
January 2010 |
£495 |
DONGKOOK Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Del Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Depsons Pharma-Company Report
|
January 2010 |
£495 |
Digna Biotech, S.L.-Company Report
|
January 2010 |
£495 |
Difass s.a.-Company Report
|
January 2010 |
£495 |
Diatos SA-Company Report
|
January 2010 |
£495 |
Disphar International BV-Company Report
|
January 2010 |
£495 |
Doetsch Grether AG-Company Report
|
January 2010 |
£495 |
Dong Sung Pharmaceutical Company Ltd.-Company Report
|
January 2010 |
£495 |
Dompe S.p.A.-Company Report
|
January 2010 |
£495 |
Diabetology Ltd-Company Report
|
January 2010 |
£495 |
DiaMedica Inc.-Company Report
|
January 2010 |
£495 |
Dermtek Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
DermaTech Pty Ltd-Company Report
|
January 2010 |
£495 |
Derma UK Ltd-Company Report
|
January 2010 |
£495 |
Desitin Arzneimittel GmbH-Company Report
|
January 2010 |
£495 |
DeveloGen AG-Company Report
|
January 2010 |
£495 |
DiaKine Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Dexcel Pharma Technologies Ltd.-Company Report
|
January 2010 |
£495 |
Endotis Pharma-Company Report
|
January 2010 |
£495 |
Enkam Pharmaceuticals A/S-Company Report
|
January 2010 |
£495 |
Fovea Pharmaceuticals SA-Company Report
|
January 2010 |
£495 |
Formac Pharmaceuticals N.V.-Company Report
|
January 2010 |
£495 |
ForTe BV-Company Report
|
January 2010 |
£495 |
Franco-Indian Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Fresenius Kabi AG-Company Report
|
January 2010 |
£495 |
Fusion Antibodies Ltd-Company Report
|
January 2010 |
£495 |
Fulford (India) Limited-Company Report
|
January 2010 |
£495 |
Fujimoto Pharmaceutical Corporation-Company Report
|
January 2010 |
£495 |
Flynn Pharma Ltd-Company Report
|
January 2010 |
£495 |
Flen Pharma-Company Report
|
January 2010 |
£495 |
Fidia farmaceutici S.p.A.-Company Report
|
January 2010 |
£495 |
FibroGen, Inc.-Company Report
|
January 2010 |
£495 |
Fertin Pharma A/S-Company Report
|
January 2010 |
£495 |
Finderm Farmaceutici s.r.l.-Company Report
|
January 2010 |
£495 |
FivePrime Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Fleming Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Flamingo Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Futura Medical plc-Company Report
|
January 2010 |
£495 |
G & W Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Geistlich-Company Report
|
January 2010 |
£495 |
Gary Pharmaceuticals P Limited-Company Report
|
January 2010 |
£495 |
Galenica s.a.-Company Report
|
January 2010 |
£495 |
Gemin X Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
GenBioPro, Inc.-Company Report
|
January 2010 |
£495 |
Gene Signal International SA-Company Report
|
January 2010 |
£495 |
GenPhar, Inc.-Company Report
|
January 2010 |
£495 |
Galenica Ltd.-Company Report
|
January 2010 |
£495 |
Galen Limited-Company Report
|
January 2010 |
£495 |
GL PharmTech Corporation-Company Report
|
January 2010 |
£495 |
GEYMONAT S.p.A.-Company Report
|
January 2010 |
£495 |
GENESIS Pharma SA-Company Report
|
January 2010 |
£495 |
Gaco Pharmaceuticals.-Company Report
|
January 2010 |
£495 |
Gador S.A.-Company Report
|
January 2010 |
£495 |
Galderma SA-Company Report
|
January 2010 |
£495 |
Galapagos nv-Company Report
|
January 2010 |
£495 |
Ferozsons Laboratories Limited-Company Report
|
January 2010 |
£495 |
Ferndale Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Essex Bio-Technology Limited-Company Report
|
January 2010 |
£495 |
Essentialis, Inc.-Company Report
|
January 2010 |
£495 |
Eskayef Bangladesh Limited-Company Report
|
January 2010 |
£495 |
Esteve-Company Report
|
January 2010 |
£495 |
Ethypharm SA-Company Report
|
January 2010 |
£495 |
Eurodrug Laboratories-Company Report
|
January 2010 |
£495 |
Euphoric Pharmaceuticals (P) Ltd-Company Report
|
January 2010 |
£495 |
Errant Gene Therapeutics, LLC-Company Report
|
January 2010 |
£495 |
Eriochem S.A.-Company Report
|
January 2010 |
£495 |
Epiphany Biosciences, Inc.-Company Report
|
January 2010 |
£495 |
EpiGenesis Pharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
Epeius Biotechnologies Corporation-Company Report
|
January 2010 |
£495 |
Epla Laboratories (Pvt.) Ltd.-Company Report
|
January 2010 |
£495 |
EquiTech Corporation-Company Report
|
January 2010 |
£495 |
Erimos Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Equis Pharm Co., Ltd.-Company Report
|
January 2010 |
£495 |
Eurofarma-Company Report
|
January 2010 |
£495 |
Everett Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Falcon Pharmaceuticals, Ltd.-Company Report
|
January 2010 |
£495 |
Fabre-Kramer Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
FSP GALENA-Company Report
|
January 2010 |
£495 |
Farmacija d.o.o.-Company Report
|
January 2010 |
£495 |
Farmaprojects S.A.-Company Report
|
January 2010 |
£495 |
Faron Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Farmoquimica S/A-Company Report
|
January 2010 |
£495 |
FIT Biotech Oyj Plc.-Company Report
|
January 2010 |
£495 |
FDC Ltd.-Company Report
|
January 2010 |
£495 |
Extrawell Pharmaceutical Holdings Limited-Company Report
|
January 2010 |
£495 |
ExonHit Therapeutics SA-Company Report
|
January 2010 |
£495 |
Evolva SA-Company Report
|
January 2010 |
£495 |
EyeGene, Inc.-Company Report
|
January 2010 |
£495 |
FAES FARMA-Company Report
|
January 2010 |
£495 |
FASgen, Inc.-Company Report
|
January 2010 |
£495 |
FARAN LABORATORIES sa-Company Report
|
January 2010 |
£495 |
DEY L.P.-Company Report
|
January 2010 |
£495 |
MOVETIS NV-Company Report
|
January 2010 |
£495 |
S.L.A. Pharma AG-Company Report
|
January 2010 |
£495 |
S.A Mithra Pharmaceuticals N.V-Company Report
|
January 2010 |
£495 |
S*BIO Pte Ltd-Company Report
|
January 2010 |
£495 |
SAWAI PHARMACEUTICAL CO.,LTD.-Company Report
|
January 2010 |
£495 |
SBI Biotech Co., Ltd.-Company Report
|
January 2010 |
£495 |
SGPharma Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
SERB Laboratories-Company Report
|
January 2010 |
£495 |
SEDICO Pharmaceuticals Company-Company Report
|
January 2010 |
£495 |
Rusan Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Rottapharm SpA-Company Report
|
January 2010 |
£495 |
Rohto Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Riyadh Pharma Medical & Cosmetic Products Co. Ltd-Company Report
|
January 2010 |
£495 |
Rimonyx Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Romark Laboratories, L.C.-Company Report
|
January 2010 |
£495 |
Rose Pharma A/S (formerly Gastrotech Pharma A/S)-Company Report
|
January 2010 |
£495 |
Rosemont Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
Rosedale Therapeutics-Company Report
|
January 2010 |
£495 |
SIFI S.p.A.-Company Report
|
January 2010 |
£495 |
SK Bio-Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Samyang Corporation-Company Report
|
January 2010 |
£495 |
Sam Chun Dang Pharm. Co.,Ltd-Company Report
|
January 2010 |
£495 |
Sager Pharma-Company Report
|
January 2010 |
£495 |
SanBio, Inc.-Company Report
|
January 2010 |
£495 |
Sanbe Farma-Company Report
|
January 2010 |
£495 |
Sanochemia Pharmazeutika AG-Company Report
|
January 2010 |
£495 |
Sandoz International GmbH-Company Report
|
January 2010 |
£495 |
Sagent Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Saga Laboratories-Company Report
|
January 2010 |
£495 |
SOPHIA LABORATORIES-Company Report
|
January 2010 |
£495 |
SKYMAX LABORATORIES PVT. LTD.-Company Report
|
January 2010 |
£495 |
SK Chemicals Life Science (formerly Dong Shin Pharmaceutical Co., Ltd.)-Company Report
|
January 2010 |
£495 |
SR Medicare Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
SRS Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
SWEDISH ORPHAN A/S-Company Report
|
January 2010 |
£495 |
SSP CO., LTD.-Company Report
|
January 2010 |
£495 |
Rib-X Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Reviva Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
REPLICor Inc.-Company Report
|
January 2010 |
£495 |
RECORDATI SpA-Company Report
|
January 2010 |
£495 |
Zymenex A/S-Company Report
|
January 2010 |
£495 |
REVOTAR Biopharmaceuticals AG-Company Report
|
January 2010 |
£495 |
RFS Pharma, LLC-Company Report
|
January 2010 |
£495 |
RPG Life Sciences Ltd.-Company Report
|
January 2010 |
£495 |
ROWA Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
RNL Bio Co., Ltd-Company Report
|
January 2010 |
£495 |
Zydus Cadila Healthcare Limited-Company Report
|
January 2010 |
£495 |
Zyber Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Zenotech Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Zelos Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Zealand Pharma A/S-Company Report
|
January 2010 |
£495 |
Zentiva, a.s. (formerly Leciva a.s.)-Company Report
|
January 2010 |
£495 |
Zenyaku Kogyo Co. Ltd.-Company Report
|
January 2010 |
£495 |
Zhejiang Huahai Pharmaceutical Co.,Ltd-Company Report
|
January 2010 |
£495 |
Zeria Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
RaQualia Pharma Inc.-Company Report
|
January 2010 |
£495 |
Rafa Laboratories, Ltd.-Company Report
|
January 2010 |
£495 |
Renovo Ltd.-Company Report
|
January 2010 |
£495 |
Reliance Life Sciences Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Rekah Pharmaceutical Industry Ltd.-Company Report
|
January 2010 |
£495 |
Representaciones e Investigaciones Medicas, S.A. de C.V-Company Report
|
January 2010 |
£495 |
Resolvyx Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Revance Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Resverlogix Corp.-Company Report
|
January 2010 |
£495 |
Regulus Therapeutics-Company Report
|
January 2010 |
£495 |
Regulon, Inc-Company Report
|
January 2010 |
£495 |
Razi Vaccine & Serum Research Institute-Company Report
|
January 2010 |
£495 |
Rare Disease Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Ranbaxy Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
ReNeuron Group plc-Company Report
|
January 2010 |
£495 |
Reata Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Redox Pharmaceutical Corporation-Company Report
|
January 2010 |
£495 |
Reckitt Benckiser Group plc.-Company Report
|
January 2010 |
£495 |
Sanovel-Company Report
|
January 2010 |
£495 |
Santaris Pharma A/S-Company Report
|
January 2010 |
£495 |
Sopharma JSCo.-Company Report
|
January 2010 |
£495 |
Solvay S.A.-Company Report
|
January 2010 |
£495 |
Snowdon Pharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
Sosei Group Corporation-Company Report
|
January 2010 |
£495 |
Sparsh Bio-Tech Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Spherics, Inc-Company Report
|
January 2010 |
£495 |
Specifar Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Speciality European Pharma Limited-Company Report
|
January 2010 |
£495 |
SkinMedica, Inc.-Company Report
|
January 2010 |
£495 |
Sirtris Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Silence Therapeutics plc (formerly SR Pharma plc)-Company Report
|
January 2010 |
£495 |
Sihuan Pharmaceutical Holdings Group Ltd.-Company Report
|
January 2010 |
£495 |
Sigma-Tau S.p.A.-Company Report
|
January 2010 |
£495 |
Sinclair Pharma plc-Company Report
|
January 2010 |
£495 |
Sino Biopharmaceutical Ltd.-Company Report
|
January 2010 |
£495 |
Sirnaomics, Inc.-Company Report
|
January 2010 |
£495 |
Sirion Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Spirig Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Spirogen Ltd.-Company Report
|
January 2010 |
£495 |
Summers Labs, Inc.-Company Report
|
January 2010 |
£495 |
Stragen Pharma SA-Company Report
|
January 2010 |
£495 |
Sterling Lab-Company Report
|
January 2010 |
£495 |
Summit plc-Company Report
|
January 2010 |
£495 |
Sun Pharmaceutical Industries Ltd.-Company Report
|
January 2010 |
£495 |
Sunward Pharmaceutical Pte Ltd-Company Report
|
January 2010 |
£495 |
Sunrise Pharmaceutical, Inc.-Company Report
|
January 2010 |
£495 |
SteriMax Inc.-Company Report
|
January 2010 |
£495 |
Stemline Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Stallergenes-Company Report
|
January 2010 |
£495 |
St. Charles Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Square Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Stallion Laboratories Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Standard Chem. & Pharm. Co., Ltd.-Company Report
|
January 2010 |
£495 |
Stelic Institute & Co.-Company Report
|
January 2010 |
£495 |
Star Laboratories (Pvt) Ltd.-Company Report
|
January 2010 |
£495 |
Sigma Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Shrooq PHARMA (PVT.) LTD.-Company Report
|
January 2010 |
£495 |
Scios Inc.-Company Report
|
January 2010 |
£495 |
Scil Technology GmbH-Company Report
|
January 2010 |
£495 |
Sciele Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Searle Pakistan LTD.-Company Report
|
January 2010 |
£495 |
Sedona Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Semafore Pharmaceuticals, Inc. (formerly ComChem Technologies)-Company Report
|
January 2010 |
£495 |
Seikagaku Corporation-Company Report
|
January 2010 |
£495 |
SciGen Limited-Company Report
|
January 2010 |
£495 |
Scandinavian Clinical Nutrition AB-Company Report
|
January 2010 |
£495 |
Sanwa Kagaku Kenkyusho Co., Ltd.-Company Report
|
January 2010 |
£495 |
Santhera Pharmaceuticals AG-Company Report
|
January 2010 |
£495 |
Santen Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Sareum Ltd-Company Report
|
January 2010 |
£495 |
Sato Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Scancell Limited-Company Report
|
January 2010 |
£495 |
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)-Company Report
|
January 2010 |
£495 |
Senexis Limited-Company Report
|
January 2010 |
£495 |
Senju Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai Sunve Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai Harvest Pharmaceutical Co.Ltd-Company Report
|
January 2010 |
£495 |
Shanghai Fosun Pharmaceutical Group Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shantha Biotechnics-Company Report
|
January 2010 |
£495 |
Shenzhen Salubris Pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
Shionogi & Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shineway Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai Dongbao Biopharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shalaks Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Serometrix LLC-Company Report
|
January 2010 |
£495 |
Serentis Ltd-Company Report
|
January 2010 |
£495 |
Sequella, Inc.-Company Report
|
January 2010 |
£495 |
Serum Institute Of India Ltd.-Company Report
|
January 2010 |
£495 |
Servier-Company Report
|
January 2010 |
£495 |
Shaklee Corporation-Company Report
|
January 2010 |
£495 |
Sevapharma a. s.-Company Report
|
January 2010 |
£495 |
Zambon Company S.p.A.-Company Report
|
January 2010 |
£495 |
Zahravi Pharmaceutical Company-Company Report
|
January 2010 |
£495 |
Troikaa Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Tripep AB-Company Report
|
January 2010 |
£495 |
Trillium Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Trophos SA-Company Report
|
January 2010 |
£495 |
Twilight Litaka Pharma Ltd.-Company Report
|
January 2010 |
£495 |
UDL Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
UCB S.A.-Company Report
|
January 2010 |
£495 |
Tzamal Medical Group Ltd-Company Report
|
January 2010 |
£495 |
Triax Pharmaceuticals, LLC.-Company Report
|
January 2010 |
£495 |
Tri-Med Pty Ltd-Company Report
|
January 2010 |
£495 |
TransPharma Medical Ltd.-Company Report
|
January 2010 |
£495 |
TransMolecular, Inc.-Company Report
|
January 2010 |
£495 |
Tramedico Holding B.V.-Company Report
|
January 2010 |
£495 |
TransTech Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Transgene Biotek Limited-Company Report
|
January 2010 |
£495 |
Tranzyme Pharma Inc.-Company Report
|
January 2010 |
£495 |
Transgene S.A.-Company Report
|
January 2010 |
£495 |
UMN Pharma Inc.-Company Report
|
January 2010 |
£495 |
URL Pharma, Inc. (formerly United Research Laboratories and Mutual Pharmaceutical Company)-Company Report
|
January 2010 |
£495 |
VHB Life Sciences Limited-Company Report
|
January 2010 |
£495 |
Urban Nutrition, LLC-Company Report
|
January 2010 |
£495 |
Upsher-Smith Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
VINS Bioproducts Ltd.-Company Report
|
January 2010 |
£495 |
VLST Corp.-Company Report
|
January 2010 |
£495 |
Vaccinogen, Inc.-Company Report
|
January 2010 |
£495 |
Vaccinex, Inc.-Company Report
|
January 2010 |
£495 |
United Biomedical, Inc.-Company Report
|
January 2010 |
£495 |
Unison Laboratories Co., Ltd-Company Report
|
January 2010 |
£495 |
Unichem Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Unibioscreen SA-Company Report
|
January 2010 |
£495 |
USV Limited-Company Report
|
January 2010 |
£495 |
Unicure Remedies Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Unimarck Healthcare Limited. (UHL)-Company Report
|
January 2010 |
£495 |
Unipharma-Company Report
|
January 2010 |
£495 |
Unipharm Ltd.-Company Report
|
January 2010 |
£495 |
Toyama Chemical Co.,Ltd.-Company Report
|
January 2010 |
£495 |
Torrent Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Temmler Pharma GmbH & Co. KG-Company Report
|
January 2010 |
£495 |
TTY BioPharm-Company Report
|
January 2010 |
£495 |
TTK Healthcare Ltd-Company Report
|
January 2010 |
£495 |
Thallion Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
The United Laboratories International Holdings Limited-Company Report
|
January 2010 |
£495 |
Therabel Group-Company Report
|
January 2010 |
£495 |
TheraQuest Biosciences-Company Report
|
January 2010 |
£495 |
Themis Medicare Ltd.-Company Report
|
January 2010 |
£495 |
TSUMURA & CO.-Company Report
|
January 2010 |
£495 |
TRx Pharma-Company Report
|
January 2010 |
£495 |
TOPIGEN Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
TMRC Co., Ltd.-Company Report
|
January 2010 |
£495 |
TIDAL LABORATORIES PVT. LTD.,-Company Report
|
January 2010 |
£495 |
TOSC INTERNATIONAL PVT. LTD.-Company Report
|
January 2010 |
£495 |
TRACON Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
TRION Pharma GmbH-Company Report
|
January 2010 |
£495 |
TRB Chemedica International S.A.-Company Report
|
January 2010 |
£495 |
Theracos, Inc.-Company Report
|
January 2010 |
£495 |
Theraptosis S.A-Company Report
|
January 2010 |
£495 |
Tolerotech Inc.-Company Report
|
January 2010 |
£495 |
Toa Eiyo Ltd.-Company Report
|
January 2010 |
£495 |
Tillotts Pharma AG-Company Report
|
January 2010 |
£495 |
Tolerx, Inc.-Company Report
|
January 2010 |
£495 |
Topotarget A/S-Company Report
|
January 2010 |
£495 |
Torii Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Toray Industries, Inc.-Company Report
|
January 2010 |
£495 |
Tillomed Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Tibotec BVBA-Company Report
|
January 2010 |
£495 |
Three Rivers Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Theratechnologies, Inc.-Company Report
|
January 2010 |
£495 |
Therapure Biopharma Inc.-Company Report
|
January 2010 |
£495 |
ThromboGenics NV-Company Report
|
January 2010 |
£495 |
Thrombotargets Corporation-Company Report
|
January 2010 |
£495 |
Tiber Laboratories, LLC-Company Report
|
January 2010 |
£495 |
Tianjin Pharmaceuticals Group Co., Ltd.-Company Report
|
January 2010 |
£495 |
Vakzine Projekt Management GmbH (VPM)-Company Report
|
January 2010 |
£495 |
Valeo Pharma Inc.-Company Report
|
January 2010 |
£495 |
Will-Pharma-Company Report
|
January 2010 |
£495 |
WhanIn Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Wellstat Therapeutics Corporation-Company Report
|
January 2010 |
£495 |
Winsome Laboratories Pvt Ltd.-Company Report
|
January 2010 |
£495 |
X-GEN Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Xencor-Company Report
|
January 2010 |
£495 |
Xel Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Xanodyne Pharmaceuticals, Inc. (formerly Xanodyne Pharmacal)-Company Report
|
January 2010 |
£495 |
Wellstat Biologics Corporation-Company Report
|
January 2010 |
£495 |
Wellspring Pharmaceutical Corporation-Company Report
|
January 2010 |
£495 |
WOCKHARDT LIMITED-Company Report
|
January 2010 |
£495 |
WINGS PHARMACEUTICALS PVT. LTD-Company Report
|
January 2010 |
£495 |
WILEX AG-Company Report
|
January 2010 |
£495 |
Wakamoto Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Wallace Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Waymade Healthcare plc-Company Report
|
January 2010 |
£495 |
Wanbury Limited-Company Report
|
January 2010 |
£495 |
Xeno Pharmaceuticals Phils, Inc.-Company Report
|
January 2010 |
£495 |
Xenome Ltd-Company Report
|
January 2010 |
£495 |
Yamazaki Teikokudo Co., Ltd.-Company Report
|
January 2010 |
£495 |
Yakult Honsha Co., Ltd.-Company Report
|
January 2010 |
£495 |
YUNGJIN PHARM. CO.,LTD-Company Report
|
January 2010 |
£495 |
Yash Pharma Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Yuhan Corporation-Company Report
|
January 2010 |
£495 |
ZARS Pharma-Company Report
|
January 2010 |
£495 |
Yung Shin Pharmaceutical-Company Report
|
January 2010 |
£495 |
YORK PHARMA PLC-Company Report
|
January 2010 |
£495 |
YOOYOUNG Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Xention Limited (formerly Xention Discovery Ltd)-Company Report
|
January 2010 |
£495 |
Xenon Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Xenon Pharma.-Company Report
|
January 2010 |
£495 |
Xepa-Soul Pattinson (Malaysia) Sdn Bhd-Company Report
|
January 2010 |
£495 |
Xigen S.A.-Company Report
|
January 2010 |
£495 |
YASOO Health Inc.-Company Report
|
January 2010 |
£495 |
Xytis, Inc.-Company Report
|
January 2010 |
£495 |
WEX Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Vivier Pharma Inc.-Company Report
|
January 2010 |
£495 |
Venus Remedies Limited-Company Report
|
January 2010 |
£495 |
Vee Excel Drugs & Pharmaceuticals Private Limited-Company Report
|
January 2010 |
£495 |
Vectura Group plc.-Company Report
|
January 2010 |
£495 |
Veropharm-Company Report
|
January 2010 |
£495 |
VersaPharm Incorporated-Company Report
|
January 2010 |
£495 |
Vichem Chemie Ltd.-Company Report
|
January 2010 |
£495 |
Verva Pharmaceuticals Pty Ltd.-Company Report
|
January 2010 |
£495 |
Vectorite Biomedica, Inc.-Company Report
|
January 2010 |
£495 |
Vaxon Biotech-Company Report
|
January 2010 |
£495 |
VasGene Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Vantia Ltd-Company Report
|
January 2010 |
£495 |
Vanguard Pharmaceutical Corp-Company Report
|
January 2010 |
£495 |
Vascular Biogenics Ltd.-Company Report
|
January 2010 |
£495 |
Vaxart, Inc.-Company Report
|
January 2010 |
£495 |
Vaxine Pty. Ltd.-Company Report
|
January 2010 |
£495 |
Vaxin, Inc.-Company Report
|
January 2010 |
£495 |
Victory Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Victus Inc.-Company Report
|
January 2010 |
£495 |
Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Company Report
|
January 2010 |
£495 |
Vitabiotics Ltd.-Company Report
|
January 2010 |
£495 |
VistaPharm, Inc.-Company Report
|
January 2010 |
£495 |
Vital Pharmaceutical Holdings Limited (formerly Vital BioTech Holdings Limited)-Company Report
|
January 2010 |
£495 |
Vitane Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Viventia Biotech, Inc.-Company Report
|
January 2010 |
£495 |
VitreoRetinal Technologies Inc.-Company Report
|
January 2010 |
£495 |
Vista Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Vision Pharma, LLC-Company Report
|
January 2010 |
£495 |
Viralytics Ltd (formerly Psiron Ltd)-Company Report
|
January 2010 |
£495 |
Vida Labs Limited-Company Report
|
January 2010 |
£495 |
Vicus Therapeutics-Company Report
|
January 2010 |
£495 |
Virionics Corporation-Company Report
|
January 2010 |
£495 |
ViroBay Inc-Company Report
|
January 2010 |
£495 |
Viron Therapeutics Inc-Company Report
|
January 2010 |
£495 |
ViroMed Co., Ltd-Company Report
|
January 2010 |
£495 |
Sunway Biotech Co.Ltd.-Company Report
|
January 2010 |
£495 |
Supernus Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Presidio Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
PregLem SA-Company Report
|
January 2010 |
£495 |
Prasco Laboratories-Company Report
|
January 2010 |
£495 |
Primus Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
ProMetic Life Sciences Inc.-Company Report
|
January 2010 |
£495 |
Probiotec Limited-Company Report
|
January 2010 |
£495 |
Probiomed, S.A. de C.V-Company Report
|
January 2010 |
£495 |
ProStrakan Group plc-Company Report
|
January 2010 |
£495 |
Popular Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Polyphor Ltd-Company Report
|
January 2010 |
£495 |
Plethora Solutions Limited-Company Report
|
January 2010 |
£495 |
Plethico Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Pisa Farmaceutica Mexicana-Company Report
|
January 2010 |
£495 |
Plexxikon Inc-Company Report
|
January 2010 |
£495 |
Polaris Group-Company Report
|
January 2010 |
£495 |
Polymun Scientific Immunbiologische Forschung GmbH-Company Report
|
January 2010 |
£495 |
Polpharma SA-Company Report
|
January 2010 |
£495 |
Procaps SA-Company Report
|
January 2010 |
£495 |
Prolexys Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Purdue Pharma L.P-Company Report
|
January 2010 |
£495 |
Protox Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Protez Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Purzer Pharmaceutical Co. Ltd.-Company Report
|
January 2010 |
£495 |
Q-Med AB-Company Report
|
January 2010 |
£495 |
Qilu Pharmaceutical CO., LTD.-Company Report
|
January 2010 |
£495 |
QRxPharma Pty Ltd-Company Report
|
January 2010 |
£495 |
ProteomTech, Inc.-Company Report
|
January 2010 |
£495 |
Protemix Corporation Limited-Company Report
|
January 2010 |
£495 |
Pronova BioPharma ASA-Company Report
|
January 2010 |
£495 |
Proneuron Biotechnologies, Inc.-Company Report
|
January 2010 |
£495 |
Prometheus Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Proper Nutrition, Inc.-Company Report
|
January 2010 |
£495 |
Proreo Pharma AG-Company Report
|
January 2010 |
£495 |
Protein Sciences Corporation-Company Report
|
January 2010 |
£495 |
ProtAffin Biotechnologie AG-Company Report
|
January 2010 |
£495 |
Piramal Healthcare Limited (formerly Nicholas Piramal India Limited)-Company Report
|
January 2010 |
£495 |
Pinnacle Pharma del Peru S.A.C.-Company Report
|
January 2010 |
£495 |
PharmEste s.r.l.-Company Report
|
January 2010 |
£495 |
Pharis Biotec GmbH-Company Report
|
January 2010 |
£495 |
Pharco Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Pharma Stulln GmbH-Company Report
|
January 2010 |
£495 |
PharmaEngine, Inc.-Company Report
|
January 2010 |
£495 |
PharmaMar-Company Report
|
January 2010 |
£495 |
PharmaIN Corporation-Company Report
|
January 2010 |
£495 |
PharmaEssentia Corp.-Company Report
|
January 2010 |
£495 |
Phafag AG-Company Report
|
January 2010 |
£495 |
Pfizer Limited-Company Report
|
January 2010 |
£495 |
Pei Li Pharmaceutical Ind. Co., Ltd.-Company Report
|
January 2010 |
£495 |
Pedinol Pharmacal Inc.-Company Report
|
January 2010 |
£495 |
Patrys Limited-Company Report
|
January 2010 |
£495 |
PepTcell Limited-Company Report
|
January 2010 |
£495 |
PepTx, Inc.-Company Report
|
January 2010 |
£495 |
Pevion Biotech Ltd.-Company Report
|
January 2010 |
£495 |
Peptimmune, Inc-Company Report
|
January 2010 |
£495 |
Pharmaceutical Associates, Inc.-Company Report
|
January 2010 |
£495 |
Pharmagenesis Inc-Company Report
|
January 2010 |
£495 |
Philusa Corporation-Company Report
|
January 2010 |
£495 |
Philogen S.p.A-Company Report
|
January 2010 |
£495 |
PhiloGene Inc.-Company Report
|
January 2010 |
£495 |
PhotoCure ASA-Company Report
|
January 2010 |
£495 |
Photopharmica Ltd-Company Report
|
January 2010 |
£495 |
Pieris AG-Company Report
|
January 2010 |
£495 |
Phynova Group Plc-Company Report
|
January 2010 |
£495 |
Pherin Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Phase 2 Discovery, Inc.-Company Report
|
January 2010 |
£495 |
Pharmascience Inc.-Company Report
|
January 2010 |
£495 |
Pharmaniaga Berhad-Company Report
|
January 2010 |
£495 |
Pharmalink AB-Company Report
|
January 2010 |
£495 |
Pharmathen S.A.-Company Report
|
January 2010 |
£495 |
Pharmbio Korea Co., Ltd-Company Report
|
January 2010 |
£495 |
Pharmstandard-Company Report
|
January 2010 |
£495 |
Pharminox Ltd-Company Report
|
January 2010 |
£495 |
Quark Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
QuatRx Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Liqvor CJSC-Company Report
|
January 2010 |
£495 |
Lipoxen-Company Report
|
January 2010 |
£495 |
Lipomed AG-Company Report
|
January 2010 |
£495 |
Living Cell Technologies Ltd-Company Report
|
January 2010 |
£495 |
Locus Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Luitpold Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Lotus Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Logical Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Lipocine Inc.-Company Report
|
January 2010 |
£495 |
Lipicard Technologies Limited-Company Report
|
January 2010 |
£495 |
LifeCycle Pharma A/S-Company Report
|
January 2010 |
£495 |
LiPlasome Pharma A/S-Company Report
|
January 2010 |
£495 |
Leuchemix-Company Report
|
January 2010 |
£495 |
LifeTec Group Limited-Company Report
|
January 2010 |
£495 |
Light Sciences Oncology, Inc.-Company Report
|
January 2010 |
£495 |
Lion Corporation-Company Report
|
January 2010 |
£495 |
LigoCyte Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Lumen Therapeutics-Company Report
|
January 2010 |
£495 |
Lupin Ltd-Company Report
|
January 2010 |
£495 |
MISSION PHARMACEUTICALS LTD.-Company Report
|
January 2010 |
£495 |
MIKA Pharma GmbH-Company Report
|
January 2010 |
£495 |
MEDLEY PHARMACEUTICALS LTD.-Company Report
|
January 2010 |
£495 |
MN Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Chikujee Therapeutics-Company Report
|
January 2010 |
£495 |
MacroGenics Inc.-Company Report
|
January 2010 |
£495 |
Maas BiolAB-Company Report
|
January 2010 |
£495 |
MEABCO A/S-Company Report
|
January 2010 |
£495 |
MDC Pharmaceuticals Pvt Ltd.-Company Report
|
January 2010 |
£495 |
Lytix Biopharma AS-Company Report
|
January 2010 |
£495 |
Lyka Labs Limited-Company Report
|
January 2010 |
£495 |
Lux Biosciences, Inc.-Company Report
|
January 2010 |
£495 |
M et P Pharma AG (formerly Mattern Pharmaceuticals AG)-Company Report
|
January 2010 |
£495 |
M.J. Group-Company Report
|
January 2010 |
£495 |
MAT Biopharma-Company Report
|
January 2010 |
£495 |
MACLEODS PHARMACEUTICALS LIMITED-Company Report
|
January 2010 |
£495 |
Lentigen Corporation-Company Report
|
January 2010 |
£495 |
Leksir Ltd.-Company Report
|
January 2010 |
£495 |
LTT Bio-Pharma Co., Ltd-Company Report
|
January 2010 |
£495 |
LIVZON Pharmaceutical Group Inc.-Company Report
|
January 2010 |
£495 |
LIBBS Farmaceutica Ltd-Company Report
|
January 2010 |
£495 |
LaborMed Pharma-Company Report
|
January 2010 |
£495 |
Laboratoires Carilene-Company Report
|
January 2010 |
£495 |
Laboratoires SMB-Company Report
|
January 2010 |
£495 |
Laboratoires Pierre Fabre SA-Company Report
|
January 2010 |
£495 |
LG Life Sciences Ltd.-Company Report
|
January 2010 |
£495 |
LFB-Company Report
|
January 2010 |
£495 |
Raazee Therapeutics (Pvt) Ltd.-Company Report
|
January 2010 |
£495 |
Quinnova Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Quest PharmaTech Inc. (formerly Altachem Pharma Ltd.)-Company Report
|
January 2010 |
£495 |
Radius Health Inc. (formerly NuVios, Inc.)-Company Report
|
January 2010 |
£495 |
LACER, S.A.-Company Report
|
January 2010 |
£495 |
LEO Pharma A/S-Company Report
|
January 2010 |
£495 |
LAVIPHARM Group-Company Report
|
January 2010 |
£495 |
Laboratoires Thea-Company Report
|
January 2010 |
£495 |
Laboratoires URGO S.A-Company Report
|
January 2010 |
£495 |
Laboratorios Zafiro, S.A. de C.V-Company Report
|
January 2010 |
£495 |
Laboratorios Salvat, S.A-Company Report
|
January 2010 |
£495 |
Laboratorios Phoenix-Company Report
|
January 2010 |
£495 |
Labtec GmbH-Company Report
|
January 2010 |
£495 |
Lannacher Heilmittel Gmbh-Company Report
|
January 2010 |
£495 |
Lawley Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Lark Laboratories-Company Report
|
January 2010 |
£495 |
Laboratorios Manuell, S.A-Company Report
|
January 2010 |
£495 |
Laboratorios Juventus, S.A.-Company Report
|
January 2010 |
£495 |
Laboratorio Teuto-Company Report
|
January 2010 |
£495 |
Laboratorio Elea SACIFYA-Company Report
|
January 2010 |
£495 |
Laboratori Guidotti SpA-Company Report
|
January 2010 |
£495 |
Laboratorios Almirall, S.A.-Company Report
|
January 2010 |
£495 |
Laboratorios CINFA-Company Report
|
January 2010 |
£495 |
Laboratorios Grin, S.A. de C.V.-Company Report
|
January 2010 |
£495 |
Laboratorios Gebro Pharma, S.A.-Company Report
|
January 2010 |
£495 |
Pascual Laboratories Inc.-Company Report
|
January 2010 |
£495 |
Paratek Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
NOVAGALI PHARMA S.A-Company Report
|
January 2010 |
£495 |
NOBEL ILAC Sanayii ve Ticaret A.S.-Company Report
|
January 2010 |
£495 |
N-Gene Research Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
NOXXON Pharma AG-Company Report
|
January 2010 |
£495 |
NTC S.r.L.-Company Report
|
January 2010 |
£495 |
Nicogen Inc.-Company Report
|
January 2010 |
£495 |
Nichi-iko Pharmaceutical Co., Ltd (formerly Nihon Iyakuhin Kogyo Co., Ltd)-Company Report
|
January 2010 |
£495 |
NicOx S.A.-Company Report
|
January 2010 |
£495 |
t2cure GmbH-Company Report
|
January 2010 |
£495 |
Tekmira Pharmaceuticals Corporation-Company Report
|
January 2010 |
£495 |
Tecnimede Group-Company Report
|
January 2010 |
£495 |
Techpool Bio-Pharma Co., LTD.-Company Report
|
January 2010 |
£495 |
Technologie Biolactis, Inc.-Company Report
|
January 2010 |
£495 |
Tehran Chemie Pharmaceutical Co.-Company Report
|
January 2010 |
£495 |
Teijin Pharma Limited-Company Report
|
January 2010 |
£495 |
Teikoku Seiyaku Co., Ltd.-Company Report
|
January 2010 |
£495 |
Teikoku Pharma USA, Inc.-Company Report
|
January 2010 |
£495 |
Nippon Chemiphar Co., Ltd.-Company Report
|
January 2010 |
£495 |
Nippon Kayaku Co., Ltd.-Company Report
|
January 2010 |
£495 |
Novelix Pharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
NovaMed Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Noscira, S.A. (formerly Neuropharma, S.A.)-Company Report
|
January 2010 |
£495 |
Novell Pharmaceutical Laboratories-Company Report
|
January 2010 |
£495 |
Novexel-Company Report
|
January 2010 |
£495 |
Nucitec, S.A. de C.V.-Company Report
|
January 2010 |
£495 |
Novopharm Limited-Company Report
|
January 2010 |
£495 |
Norwood Immunology Limited-Company Report
|
January 2010 |
£495 |
North China Pharmaceutical Group Corp-Company Report
|
January 2010 |
£495 |
Nissan Chemical Industries, Ltd.-Company Report
|
January 2010 |
£495 |
Nippon Zoki Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Nippon Shinyaku Co., Ltd.-Company Report
|
January 2010 |
£495 |
Nisshin Seifun Group Inc.-Company Report
|
January 2010 |
£495 |
Nitec Pharma AG-Company Report
|
January 2010 |
£495 |
Norgine-Company Report
|
January 2010 |
£495 |
Nobelpharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Taxolog, Inc.-Company Report
|
January 2010 |
£495 |
Tau Therapeutics-Company Report
|
January 2010 |
£495 |
Synokem Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Synmosa Biopharma Corporation-Company Report
|
January 2010 |
£495 |
Synmedic Laboratories-Company Report
|
January 2010 |
£495 |
Synosia Therapeutics (formerly Synosis Therapeutics)-Company Report
|
January 2010 |
£495 |
Synpac-Kingdom Pharmaceuticals Co Ltd-Company Report
|
January 2010 |
£495 |
Syntopix Group plc-Company Report
|
January 2010 |
£495 |
Synthon BV-Company Report
|
January 2010 |
£495 |
Synteza Ltd-Company Report
|
January 2010 |
£495 |
Syndax Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Syncom Formulations (India) Ltd-Company Report
|
January 2010 |
£495 |
Suven Life Sciences Limited-Company Report
|
January 2010 |
£495 |
Surface Logix, Inc.-Company Report
|
January 2010 |
£495 |
Supratek Pharma Inc-Company Report
|
January 2010 |
£495 |
Swiss Pharma Nigeria Limited-Company Report
|
January 2010 |
£495 |
Symphogen A/S-Company Report
|
January 2010 |
£495 |
Synairgen plc-Company Report
|
January 2010 |
£495 |
SynZyme Technologies LLC-Company Report
|
January 2010 |
£495 |
Syntrix Biosystems, Inc.-Company Report
|
January 2010 |
£495 |
Systopic Laboratories Pvt. ltd.-Company Report
|
January 2010 |
£495 |
Tanmo Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Tampei Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Taligen Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Targa Therapeutics Corp.-Company Report
|
January 2010 |
£495 |
TargeGen, Inc.-Company Report
|
January 2010 |
£495 |
TargetDrug-Company Report
|
January 2010 |
£495 |
Targepeutics, Inc.-Company Report
|
January 2010 |
£495 |
Talecris Biotherapeutics-Company Report
|
January 2010 |
£495 |
Takeda Pharmaceutical Company Limited-Company Report
|
January 2010 |
£495 |
TaiGen Biotechnology Co., Ltd.-Company Report
|
January 2010 |
£495 |
Tablets (India) Limited-Company Report
|
January 2010 |
£495 |
T3A Industrial-Company Report
|
January 2010 |
£495 |
Taiho Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Taisho Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Taiwan Panbiotic Laboratories Co. Ltd.-Company Report
|
January 2010 |
£495 |
Taiwan Liposome Company-Company Report
|
January 2010 |
£495 |
Numerate, Inc.-Company Report
|
January 2010 |
£495 |
Nuvo Research Inc. (formerly Dimethaid Research Inc.)-Company Report
|
January 2010 |
£495 |
PALAU PHARMA-Company Report
|
January 2010 |
£495 |
PAION-Company Report
|
January 2010 |
£495 |
Ozone Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
PARI Pharma (formerly PARI Aerosol Research Institute)-Company Report
|
January 2010 |
£495 |
PDC Biotech GmbH-Company Report
|
January 2010 |
£495 |
PR Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
PLx Pharma Inc.-Company Report
|
January 2010 |
£495 |
PH&T S.p.A.-Company Report
|
January 2010 |
£495 |
Oxford BioMedica plc-Company Report
|
January 2010 |
£495 |
Oxagen Limited-Company Report
|
January 2010 |
£495 |
Osmotica Pharmaceutical Corp.-Company Report
|
January 2010 |
£495 |
Ortin Laboratories Limited-Company Report
|
January 2010 |
£495 |
Ortho-McNeil, Inc.-Company Report
|
January 2010 |
£495 |
Osprey Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Othera Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Otsuka Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Otis Clapp and Buffington-Company Report
|
January 2010 |
£495 |
PT Bernofarm-Company Report
|
January 2010 |
£495 |
PT Darya-Varia Laboratoria Tbk-Company Report
|
January 2010 |
£495 |
Panacea Biotec Ltd-Company Report
|
January 2010 |
£495 |
Pamlab, L.L.C. (formerly Pan American Laboratories, Inc.)-Company Report
|
January 2010 |
£495 |
Paloma Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Panacea Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Pangenetics BV-Company Report
|
January 2010 |
£495 |
Pantarhei Bioscience-Company Report
|
January 2010 |
£495 |
Panjon Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Paladin Labs Inc.-Company Report
|
January 2010 |
£495 |
Paddock Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
PT. Pyridam Farma Tbk-Company Report
|
January 2010 |
£495 |
PT Kimia Farma Tbk-Company Report
|
January 2010 |
£495 |
PT Kalbe Farma Tbk.-Company Report
|
January 2010 |
£495 |
Pacgen Biopharmaceuticals Corporation-Company Report
|
January 2010 |
£495 |
Pacific Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Pacira Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Pacific Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Orivas-Company Report
|
January 2010 |
£495 |
Orion Corporation-Company Report
|
January 2010 |
£495 |
Odan Laboratories Ltd-Company Report
|
January 2010 |
£495 |
OctoPlus N.V.-Company Report
|
January 2010 |
£495 |
Octapharma AG-Company Report
|
January 2010 |
£495 |
Oftalmoquimica Ltda.-Company Report
|
January 2010 |
£495 |
Okairos S.r.l.-Company Report
|
January 2010 |
£495 |
Omega Laboratories Limited-Company Report
|
January 2010 |
£495 |
Okopharm GmbH-Company Report
|
January 2010 |
£495 |
Ochoa Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Ocera Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd-Company Report
|
January 2010 |
£495 |
OM PHARMA-Company Report
|
January 2010 |
£495 |
Nycomed-Company Report
|
January 2010 |
£495 |
ORION Laboratories Pty Ltd-Company Report
|
January 2010 |
£495 |
ORLING spol. s r.o.-Company Report
|
January 2010 |
£495 |
Oboi Laboratories-Company Report
|
January 2010 |
£495 |
Oakwood Laboratories, L.L.C.-Company Report
|
January 2010 |
£495 |
Omega Pharma NV-Company Report
|
January 2010 |
£495 |
OmegaGenesis-Company Report
|
January 2010 |
£495 |
Orange Drugs Limited-Company Report
|
January 2010 |
£495 |
Onyvax Limited-Company Report
|
January 2010 |
£495 |
Onset Therapeutics-Company Report
|
January 2010 |
£495 |
Ordain Health Care Pvt. Ltd-Company Report
|
January 2010 |
£495 |
Orexo AB-Company Report
|
January 2010 |
£495 |
Orient Europharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Organogenesis Inc.-Company Report
|
January 2010 |
£495 |
Ono Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Onepharm-Company Report
|
January 2010 |
£495 |
OncoMune, LLC-Company Report
|
January 2010 |
£495 |
Omrix Biopharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
Omeros Corporation-Company Report
|
January 2010 |
£495 |
Oncolys Biopharma Inc.-Company Report
|
January 2010 |
£495 |
Onconova Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Oncosense-Company Report
|
January 2010 |
£495 |
Oncoscience AG-Company Report
|
January 2010 |
£495 |
Maiden Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
China Shineway Pharmaceutical Group Limited-Company Report
|
January 2010 |
£495 |
IL Dong Pharmaceutical Company-Company Report
|
January 2010 |
£495 |
IBSS BIOMED S.A.-Company Report
|
January 2010 |
£495 |
Hypermarcas S.A.-Company Report
|
January 2010 |
£495 |
ILS Inc. (formerly Ito Life Sciences Inc.)-Company Report
|
January 2010 |
£495 |
Ichor Medical Systems, Inc.-Company Report
|
January 2010 |
£495 |
Ilsung pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
Ikaria Holdings, Inc.-Company Report
|
January 2010 |
£495 |
Ikano Therapeutics, Inc. (ITI) (formerly Intranasal Therapeutics, Inc.)-Company Report
|
January 2010 |
£495 |
Hygeia Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Huons Co., Ltd.-Company Report
|
January 2010 |
£495 |
Hindustan Antibiotics Limited-Company Report
|
January 2010 |
£495 |
Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG-Company Report
|
January 2010 |
£495 |
Henderson Morley plc-Company Report
|
January 2010 |
£495 |
Hindustan Biosynth Ltd-Company Report
|
January 2010 |
£495 |
Hualan Biological Engineering Inc.-Company Report
|
January 2010 |
£495 |
Human BioSciences, Inc.-Company Report
|
January 2010 |
£495 |
Huangshan Tianmu Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
ImmunoVaccine Technologies Inc.-Company Report
|
January 2010 |
£495 |
Implicit Bioscience Limited-Company Report
|
January 2010 |
£495 |
Institute of Medicinal Molecular Design, Inc. (IMMD)-Company Report
|
January 2010 |
£495 |
Institut Rosell-Lallemand-Company Report
|
January 2010 |
£495 |
Insight Pharmaceuticals Corp.-Company Report
|
January 2010 |
£495 |
Insys Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
ISA Pharmaceuticals B.V.-Company Report
|
January 2010 |
£495 |
Intellikine, Inc.-Company Report
|
January 2010 |
£495 |
IntelliPharmaCeutics Corp.-Company Report
|
January 2010 |
£495 |
Innovative Technologies-Company Report
|
January 2010 |
£495 |
Innate Therapeutics Limited (formerly Virionyx Corporation Limited)-Company Report
|
January 2010 |
£495 |
InNexus Biotechnology Inc.-Company Report
|
January 2010 |
£495 |
InCode BioPharmaceutics, Inc.-Company Report
|
January 2010 |
£495 |
ImuThes Therapeutics Ltd.-Company Report
|
January 2010 |
£495 |
Incepta Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Indian Immunologicals Limited-Company Report
|
January 2010 |
£495 |
Innate Pharma-Company Report
|
January 2010 |
£495 |
Indus Biotech Private Limited-Company Report
|
January 2010 |
£495 |
Helicon Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Hebi Health Care-Company Report
|
January 2010 |
£495 |
GlaxoSmithKline plc-Company Report
|
January 2010 |
£495 |
GlaxoSmithKline K.K.-Company Report
|
January 2010 |
£495 |
Getwell Life Sciences India Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Gliknik Inc.-Company Report
|
January 2010 |
£495 |
Global Napi Pharmaceuticals-Company Report
|
January 2010 |
£495 |
GlycoMar Limited-Company Report
|
January 2010 |
£495 |
Globalpharma Co LLC-Company Report
|
January 2010 |
£495 |
Global Pharma Healthcare Pvt Ltd-Company Report
|
January 2010 |
£495 |
GW Pharmaceuticals plc-Company Report
|
January 2010 |
£495 |
Gentium S.p.A.-Company Report
|
January 2010 |
£495 |
Genepharm Group-Company Report
|
January 2010 |
£495 |
Genentech, Inc.-Company Report
|
January 2010 |
£495 |
GenPharma International Pvt.Ltd.-Company Report
|
January 2010 |
£495 |
Genericon Pharma-Company Report
|
January 2010 |
£495 |
Genexo sp. z o.o.-Company Report
|
January 2010 |
£495 |
Genopharm-Company Report
|
January 2010 |
£495 |
Genomma Lab Internacional, S.A.B de C.V.-Company Report
|
January 2010 |
£495 |
Great Eastern Drug Co. Ltd.-Company Report
|
January 2010 |
£495 |
GreenPeptide Co., Ltd.-Company Report
|
January 2010 |
£495 |
Harson Laboratories-Company Report
|
January 2010 |
£495 |
HELP S.A.-Company Report
|
January 2010 |
£495 |
Han Wha Pharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Hasco-Lek-Company Report
|
January 2010 |
£495 |
Health Protection Agency-Company Report
|
January 2010 |
£495 |
Heat Biologics, Inc-Company Report
|
January 2010 |
£495 |
Healthcare Brands International Limited-Company Report
|
January 2010 |
£495 |
Hainan Haiyao Co., Ltd.-Company Report
|
January 2010 |
£495 |
Hainan Hailing Pharmaceutical Corp. Ltd.-Company Report
|
January 2010 |
£495 |
Grupo TechSphere-Company Report
|
January 2010 |
£495 |
Grupo Azevedos-Company Report
|
January 2010 |
£495 |
Group Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Guangzhou Baiyunshan Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Guilin Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
H. Lundbeck A/S-Company Report
|
January 2010 |
£495 |
Gulf Pharmaceutical Industries (JULPHAR)-Company Report
|
January 2010 |
£495 |
Intradigm Corporation-Company Report
|
January 2010 |
£495 |
Inventia Healthcare Private Limited (formerly Themis Laboratories Private Ltd)-Company Report
|
January 2010 |
£495 |
Laboratorios Silanes, S.A. de C.V.-Company Report
|
January 2010 |
£495 |
Laboratorios Serral-Company Report
|
January 2010 |
£495 |
Laboratorios SAVAL-Company Report
|
January 2010 |
£495 |
Laboratorios Solfran S.A.-Company Report
|
January 2010 |
£495 |
Landsteiner Scientific, S.A. de C.V.-Company Report
|
January 2010 |
£495 |
LegoChem Biosciences, Inc (LCB)-Company Report
|
January 2010 |
£495 |
Lee's Pharmaceutical Holdings Ltd-Company Report
|
January 2010 |
£495 |
Lantibio, Inc.-Company Report
|
January 2010 |
£495 |
Laboratorios Normon S.A.-Company Report
|
January 2010 |
£495 |
Laboratorios Hormona-Company Report
|
January 2010 |
£495 |
Laboratoires Mayoly Spindler-Company Report
|
January 2010 |
£495 |
Laboratoires Genevrier-Company Report
|
January 2010 |
£495 |
Laboratoires Expanscience S.A.-Company Report
|
January 2010 |
£495 |
Laboratorios Rubio, S.A.-Company Report
|
January 2010 |
£495 |
LAILA Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Laboratorios Casen Fleet-Company Report
|
January 2010 |
£495 |
LEOVAN PHARMACEUTICALS-Company Report
|
January 2010 |
£495 |
Life Line Biotech Ltd.-Company Report
|
January 2010 |
£495 |
Lifecare Innovations Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
MacuSight, Inc.-Company Report
|
January 2010 |
£495 |
MEDGEN Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Luye Pharma Group Ltd. (formerly AsiaPharm Group Ltd.)-Company Report
|
January 2010 |
£495 |
Magis Farmaceutici S.p.A.-Company Report
|
January 2010 |
£495 |
Mankind Pharma Limited-Company Report
|
January 2010 |
£495 |
Maroon Biotech Corp.-Company Report
|
January 2010 |
£495 |
Marksans Pharma-Company Report
|
January 2010 |
£495 |
Lundbeck Inc. (formerly OVATION Pharmaceuticals, Inc.)-Company Report
|
January 2010 |
£495 |
Louis Widmer AG-Company Report
|
January 2010 |
£495 |
Lincoln Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
Limerick BioPharma, Inc. (formerly Limerick NeuroSciences, Inc.)-Company Report
|
January 2010 |
£495 |
Lightlake Sinclair Ltd.-Company Report
|
January 2010 |
£495 |
Liomont-Company Report
|
January 2010 |
£495 |
Llorens Pharmaceutical International Division, Inc.-Company Report
|
January 2010 |
£495 |
Lorus Therapeutics Inc-Company Report
|
January 2010 |
£495 |
LPC Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
Labopharm Inc-Company Report
|
January 2010 |
£495 |
LABORATORIOS FARMACEUTICOS ROVI, S.A-Company Report
|
January 2010 |
£495 |
JOSWE Medical-Company Report
|
January 2010 |
£495 |
Jenrin Discovery, Inc.-Company Report
|
January 2010 |
£495 |
Jenapharm GmbH & Co. KG-Company Report
|
January 2010 |
£495 |
Jiangsu Hansen Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Jiangsu Lianhuan Pharmaceutical Group-Company Report
|
January 2010 |
£495 |
Joriver Research & development Center-Company Report
|
January 2010 |
£495 |
Jordanian Pharmaceutical Manufacturing Co. PLC-Company Report
|
January 2010 |
£495 |
Jintan SongSheng medical and chemical Co., Ltd-Company Report
|
January 2010 |
£495 |
Jazeera Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
Janssen Pharmaceutical K.K.-Company Report
|
January 2010 |
£495 |
Isotechnika Pharma Inc.-Company Report
|
January 2010 |
£495 |
Iroko Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Ipsen-Company Report
|
January 2010 |
£495 |
JAKA 80 AD-Company Report
|
January 2010 |
£495 |
JHP Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Jamjoom Pharma-Company Report
|
January 2010 |
£495 |
Jade Pharmaceutical Inc-Company Report
|
January 2010 |
£495 |
Jubilant Organosys Ltd.-Company Report
|
January 2010 |
£495 |
Juvaris BioTherapeutics, Inc-Company Report
|
January 2010 |
£495 |
Kotra Pharma (M) Sdn. Bhd. (KPM)-Company Report
|
January 2010 |
£495 |
Kotobuki Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Korean Drug Co., Ltd.-Company Report
|
January 2010 |
£495 |
Kurtsan Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Kuwait Saudi Pharmaceutical Industries Co.-Company Report
|
January 2010 |
£495 |
LABORATOIRES LISAPHARM-Company Report
|
January 2010 |
£495 |
Kyto BioPharma Inc-Company Report
|
January 2010 |
£495 |
Korea United Pharm, Inc.-Company Report
|
January 2010 |
£495 |
KV Pharmaceutical Company-Company Report
|
January 2010 |
£495 |
Karus Therapeutics-Company Report
|
January 2010 |
£495 |
Kaigen Co., Ltd.-Company Report
|
January 2010 |
£495 |
KAEL-GemVax-Company Report
|
January 2010 |
£495 |
Kelun Pharmaceutical-Company Report
|
January 2010 |
£495 |
Kendrick Farmaceutica-Company Report
|
January 2010 |
£495 |
Khandelwal Laboratories Pvt. Ltd-Company Report
|
January 2010 |
£495 |
Keryos SpA-Company Report
|
January 2010 |
£495 |
GenMont Biotech Inc.-Company Report
|
January 2010 |
£495 |
GenKyoTex S.A.-Company Report
|
January 2010 |
£495 |
Centocor Ortho Biotech Inc.-Company Report
|
January 2010 |
£495 |
CIS Pharma-Company Report
|
January 2010 |
£495 |
CHUGAI PHARMACEUTICAL CO., LTD-Company Report
|
January 2010 |
£495 |
CepTor Corporation-Company Report
|
January 2010 |
£495 |
CerRx, Inc.-Company Report
|
January 2010 |
£495 |
Charleston Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Changzhou Pharmaceutical Factory-Company Report
|
January 2010 |
£495 |
Changzhou Fangyuan Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Celtic Pharma Management L.P-Company Report
|
January 2010 |
£495 |
Celtic Biotech Ltd.-Company Report
|
January 2010 |
£495 |
CellAct Pharma GmbH-Company Report
|
January 2010 |
£495 |
Cell Biotech Co., Ltd-Company Report
|
January 2010 |
£495 |
Celentyx Limited-Company Report
|
January 2010 |
£495 |
Cellerix-Company Report
|
January 2010 |
£495 |
Celleron Therapeutics Ltd-Company Report
|
January 2010 |
£495 |
Celon Laboratories Limited-Company Report
|
January 2010 |
£495 |
Cellmid Ltd-Company Report
|
January 2010 |
£495 |
ChemGenex Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
China Medical System Holdings Limited-Company Report
|
January 2010 |
£495 |
Croma Pharma GmbH-Company Report
|
January 2010 |
£495 |
Covalon Technologies Ltd.-Company Report
|
January 2010 |
£495 |
Cougar Biotechnology, Inc.-Company Report
|
January 2010 |
£495 |
Crown Laboratories, Inc.-Company Report
|
January 2010 |
£495 |
Crucell N.V.-Company Report
|
January 2010 |
£495 |
Cytos Biotechnology AG-Company Report
|
January 2010 |
£495 |
Cytorex Biosciences, Inc-Company Report
|
January 2010 |
£495 |
Cosar Pharmaceutical Co.-Company Report
|
January 2010 |
£495 |
CorePharma LLC-Company Report
|
January 2010 |
£495 |
Clinuvel Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Chunggei Pharm. Co., Ltd-Company Report
|
January 2010 |
£495 |
Chinoin Pharmaceutical Products, S.A DE C.V-Company Report
|
January 2010 |
£495 |
Cognosci, Inc.-Company Report
|
January 2010 |
£495 |
Combe Incorporated-Company Report
|
January 2010 |
£495 |
Cooper Maroc-Company Report
|
January 2010 |
£495 |
Consilient Health Ltd.-Company Report
|
January 2010 |
£495 |
CeNeRx BioPharma, Inc.-Company Report
|
January 2010 |
£495 |
Catalyst Biosciences Inc.-Company Report
|
January 2010 |
£495 |
Biotecnol SA-Company Report
|
January 2010 |
£495 |
Biosyntech Inc-Company Report
|
January 2010 |
£495 |
Bionucleon S.r.l.-Company Report
|
January 2010 |
£495 |
Biotica Technology Limited-Company Report
|
January 2010 |
£495 |
Biovel Life Sciences (P) Limited-Company Report
|
January 2010 |
£495 |
Blackmores-Company Report
|
January 2010 |
£495 |
Biovista Inc.-Company Report
|
January 2010 |
£495 |
Bioven Sdn. Bhd.-Company Report
|
January 2010 |
£495 |
Bioniche Pharma USA, LLC-Company Report
|
January 2010 |
£495 |
Bioniche Life Sciences Inc-Company Report
|
January 2010 |
£495 |
Biocon Ltd-Company Report
|
January 2010 |
£495 |
Bioclonetics Inc-Company Report
|
January 2010 |
£495 |
Biochem Pharmaceutical Industries Ltd.-Company Report
|
January 2010 |
£495 |
Bioiberica, S.A.-Company Report
|
January 2010 |
£495 |
Biokine Therapeutics Ltd.-Company Report
|
January 2010 |
£495 |
Biomeks-Company Report
|
January 2010 |
£495 |
Biolotus Biotech-Company Report
|
January 2010 |
£495 |
Bluefish Pharmaceuticals AB-Company Report
|
January 2010 |
£495 |
Borshchahivskiy Chemical-Pharmaceutical Plant-Company Report
|
January 2010 |
£495 |
Calmune Corporation-Company Report
|
January 2010 |
£495 |
Calistoga Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Cadila Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Camus Pharma Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Canixa Life Sciences-Company Report
|
January 2010 |
£495 |
Cardiome Pharma Corp.-Company Report
|
January 2010 |
£495 |
Caplin Point Laboratories Ltd-Company Report
|
January 2010 |
£495 |
CCM Pharmaceuticals Sdn Bhd-Company Report
|
January 2010 |
£495 |
CCM Duopharma Biotech Bhd (CCMD)-Company Report
|
January 2010 |
£495 |
Brawn Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
BrainCells Inc.-Company Report
|
January 2010 |
£495 |
Bracco Group-Company Report
|
January 2010 |
£495 |
Bristol-Myers K.K.-Company Report
|
January 2010 |
£495 |
Broad Intelligence International Pharmaceutical Holdings Limited.-Company Report
|
January 2010 |
£495 |
C.B. Fleet Company, Inc.-Company Report
|
January 2010 |
£495 |
Burzynski Research Institute, Inc-Company Report
|
January 2010 |
£495 |
DEMO S.A.-Company Report
|
January 2010 |
£495 |
DESMA PHARMA Group-Company Report
|
January 2010 |
£495 |
Functional Genetics Inc.-Company Report
|
January 2010 |
£495 |
FunZyme BioTechnologies S.A.-Company Report
|
January 2010 |
£495 |
Fuji Chemical Industry Co., Ltd.-Company Report
|
January 2010 |
£495 |
EMS Sigma Pharma Group-Company Report
|
January 2010 |
£495 |
EXIR PHARMACEUTICAL CO.-Company Report
|
January 2010 |
£495 |
Empree Medicaments (India) Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Elysium Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
EluSys Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Fresenius SE-Company Report
|
January 2010 |
£495 |
Fresenius Kabi Oncology Ltd. (formerly Dabur Pharma Limited)-Company Report
|
January 2010 |
£495 |
Fidson Healthcare Plc-Company Report
|
January 2010 |
£495 |
Ferring International Center S.A.-Company Report
|
January 2010 |
£495 |
Feron Life Sciences-Company Report
|
January 2010 |
£495 |
Foamix Ltd.-Company Report
|
January 2010 |
£495 |
Fornix Biosciences N.V.-Company Report
|
January 2010 |
£495 |
Freedom Eye Ltd-Company Report
|
January 2010 |
£495 |
Fourrts (India) Laboratories Pvt.Limited-Company Report
|
January 2010 |
£495 |
Empresas Andromaco S. A.-Company Report
|
January 2010 |
£495 |
Endacea, Inc.-Company Report
|
January 2010 |
£495 |
Gamida Cell Ltd.-Company Report
|
January 2010 |
£495 |
Galenika a.d.-Company Report
|
January 2010 |
£495 |
GANYMED Pharmaceuticals AG-Company Report
|
January 2010 |
£495 |
Ganeden Biotech, Inc.-Company Report
|
January 2010 |
£495 |
Garnet BioTherapeutics (formerly Neuronyx, Inc.)-Company Report
|
January 2010 |
£495 |
Gemini Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Gedeon Richter Plc.-Company Report
|
January 2010 |
£495 |
GA Pharmaceuticals SA-Company Report
|
January 2010 |
£495 |
EyeGate Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Epoch Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
EpiVax, Inc.-Company Report
|
January 2010 |
£495 |
Ensemble Discovery-Company Report
|
January 2010 |
£495 |
Esperion Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Eurand N.V.-Company Report
|
January 2010 |
£495 |
Evotec AG-Company Report
|
January 2010 |
£495 |
Eusa Pharma (Europe) Ltd.-Company Report
|
January 2010 |
£495 |
Fem Care Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Farmapol Spolka z o.o.-Company Report
|
January 2010 |
£495 |
Destiny Pharma, Ltd.-Company Report
|
January 2010 |
£495 |
Desano-Company Report
|
January 2010 |
£495 |
DermAvance Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Development Center for Biotechnology (DCB)-Company Report
|
January 2010 |
£495 |
Dey's Medical Stores (Manufacturing) Limited-Company Report
|
January 2010 |
£495 |
DM Pharma-Company Report
|
January 2010 |
£495 |
Diamyd Medical AB-Company Report
|
January 2010 |
£495 |
Demegen, Inc.-Company Report
|
January 2010 |
£495 |
Deef Pharmaceutical Company Saudi Arabia Go-Company Report
|
January 2010 |
£495 |
Daana Pharmaceutical Company-Company Report
|
January 2010 |
£495 |
DIREVO Industrial Biotechnology GmbH-Company Report
|
January 2010 |
£495 |
DIFFUCAP-Company Report
|
January 2010 |
£495 |
Dae han New Pharm Co., Ltd.-Company Report
|
January 2010 |
£495 |
Dar Al Dawa Development & Investment Co. Ltd.-Company Report
|
January 2010 |
£495 |
Davi II - Farmaceutica S.A.-Company Report
|
January 2010 |
£495 |
Daval International Ltd-Company Report
|
January 2010 |
£495 |
DoNatur GmbH-Company Report
|
January 2010 |
£495 |
Dr Reddys Laboratories Ltd-Company Report
|
January 2010 |
£495 |
Eli Lilly Japan K.K.-Company Report
|
January 2010 |
£495 |
Eisai Co., Ltd.-Company Report
|
January 2010 |
£495 |
Eiger BioPharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
F. Hoffmann-La Roche Ltd-Company Report
|
January 2010 |
£495 |
FCB-Pharmicell Co.,Ltd.-Company Report
|
January 2010 |
£495 |
FPL Pharma-Company Report
|
January 2010 |
£495 |
FIBREX Medical Inc.-Company Report
|
January 2010 |
£495 |
Egyptian International Pharmaceutical Industries Co. (EIPICO)-Company Report
|
January 2010 |
£495 |
Eczacibasi-Zentiva-Company Report
|
January 2010 |
£495 |
Dr. Ritsert Pharma GmbH & Co KG-Company Report
|
January 2010 |
£495 |
Dr. R. Pfleger Chemische Fabrik GmbH-Company Report
|
January 2010 |
£495 |
Dr. F. Frik Ilac San. Ve Tic. A. S.-Company Report
|
January 2010 |
£495 |
Dream Pharma Corp.-Company Report
|
January 2010 |
£495 |
Eagle Pharmaceuticals Pty Ltd-Company Report
|
January 2010 |
£495 |
Ecopharm-Company Report
|
January 2010 |
£495 |
Ecobi Farmaceutici s.a.s.-Company Report
|
January 2010 |
£495 |
MaxCyte, Inc-Company Report
|
January 2010 |
£495 |
Medagro International-Company Report
|
January 2010 |
£495 |
Sorbent Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
SoluBest-Company Report
|
January 2010 |
£495 |
SkyePharma Plc-Company Report
|
January 2010 |
£495 |
Sothema-Company Report
|
January 2010 |
£495 |
South African Tuberculosis Vaccine Initiative (SATVI)-Company Report
|
January 2010 |
£495 |
STADA Arzneimittel AG-Company Report
|
January 2010 |
£495 |
Spinal Cord Therapeutics GmbH (SCT) (formerly Neuraxo Biopharmaceuticals GmbH)-Company Report
|
January 2010 |
£495 |
SpePharm Holding BV-Company Report
|
January 2010 |
£495 |
Sinsin Pharmaceutical Co. Ltd-Company Report
|
January 2010 |
£495 |
Sinobiopharma, Inc.-Company Report
|
January 2010 |
£495 |
Sigmapharm Arzneimittel GmbH & Co KG-Company Report
|
January 2010 |
£495 |
Siena Biotech S.p.A.-Company Report
|
January 2010 |
£495 |
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Silarx Pharmaceuticals Inc-Company Report
|
January 2010 |
£495 |
Silom Medical Co Ltd-Company Report
|
January 2010 |
£495 |
SimcereÿPharmaceutical Group-Company Report
|
January 2010 |
£495 |
Silvestre Labs-Company Report
|
January 2010 |
£495 |
Star Drugs and Research Labs Ltd.-Company Report
|
January 2010 |
£495 |
Starpharma Holdings Ltd-Company Report
|
January 2010 |
£495 |
Systagenix Wound Management-Company Report
|
January 2010 |
£495 |
Synerx Pharma-Company Report
|
January 2010 |
£495 |
Synergy Healthcare Limited-Company Report
|
January 2010 |
£495 |
TCA Cellular Therapy, LLC-Company Report
|
January 2010 |
£495 |
THE ARAB PHARMACEUTICAL MANUFACTURING CO. LTD. (APM)-Company Report
|
January 2010 |
£495 |
Taiwan Biotech Co., Ltd.-Company Report
|
January 2010 |
£495 |
Taejoon Pharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Synageva BioPharma (formerly AviGenics, Inc.)-Company Report
|
January 2010 |
£495 |
Sylentis S.A.U.-Company Report
|
January 2010 |
£495 |
Streuli Pharma AG-Company Report
|
January 2010 |
£495 |
Stewart-Jackson Pharmacal, Inc.-Company Report
|
January 2010 |
£495 |
Stem Cell Therapeutics Corp.-Company Report
|
January 2010 |
£495 |
Strides Arcolab Limited-Company Report
|
January 2010 |
£495 |
Sunways India Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Sygnis Pharma AG-Company Report
|
January 2010 |
£495 |
Surya Pharmaceutical Limited-Company Report
|
January 2010 |
£495 |
Shreya Life Sciences Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
SSL International plc-Company Report
|
January 2010 |
£495 |
Seoul Pharma Co., Ltd.-Company Report
|
January 2010 |
£495 |
Sentinel Oncology Limited-Company Report
|
January 2010 |
£495 |
Seaford Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Sepracor Inc.-Company Report
|
January 2010 |
£495 |
Sepracor Pharmaceuticals, Inc. (formerly Oryx Pharmaceuticals Inc.)-Company Report
|
January 2010 |
£495 |
Shalina Healthcare-Company Report
|
January 2010 |
£495 |
Shaanxi Jiali Pharmaceuticals Co., Ltd.-Company Report
|
January 2010 |
£495 |
Servier Canada Inc-Company Report
|
January 2010 |
£495 |
SEPS Pharma NV-Company Report
|
January 2010 |
£495 |
sanofi-aventis K.K.-Company Report
|
January 2010 |
£495 |
Sangart, Inc.-Company Report
|
January 2010 |
£495 |
Samsung Pharm-Company Report
|
January 2010 |
£495 |
Samil Pharm. Co. Ltd.-Company Report
|
January 2010 |
£495 |
Sanjivani Paranteral, Ltd.-Company Report
|
January 2010 |
£495 |
Sanofi-aventis-Company Report
|
January 2010 |
£495 |
Santen Oy-Company Report
|
January 2010 |
£495 |
Sante Naturelle A.G. Ltd-Company Report
|
January 2010 |
£495 |
Shandong Lukang Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Shandong Luoxin Pharmacy Stock Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shenzhen Neptunus Interlong Bio-Tech Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shenzhen Main Luck Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Shenzhen Zhijun Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shifa Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
SRI International-Company Report
|
January 2010 |
£495 |
Shinpoong Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
ShenZhen Hybio Engineering Co., Ltd.-Company Report
|
January 2010 |
£495 |
Sharon Bio Medicine Limited (formerly Sharon Pharma Chem Limited)-Company Report
|
January 2010 |
£495 |
Shanghai Trifecta Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai CP Guojian Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai United Cell Biotechnology Co., Ltd.-Company Report
|
January 2010 |
£495 |
Shanghai Zhongxi Pharmaceutical co., Ltd.-Company Report
|
January 2010 |
£495 |
Shaphaco Pharmaceutical-Company Report
|
January 2010 |
£495 |
Shanxi Weiqida Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Tallinna Farmaatsiatehase AS (TFT)-Company Report
|
January 2010 |
£495 |
Tasly Group-Company Report
|
January 2010 |
£495 |
Wuhan Grand Pharmaceutical Group Co., Ltd-Company Report
|
January 2010 |
£495 |
WraSer Pharmaceuticals-Company Report
|
January 2010 |
£495 |
WOORIDUL LIFE SCIENCES LTD-Company Report
|
January 2010 |
£495 |
Wuhan Humanwell Hi-Tech Industry Co., LTD.-Company Report
|
January 2010 |
£495 |
Wuyi International Pharmaceutical Company Limited-Company Report
|
January 2010 |
£495 |
Xi'an Libang Pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
Xi'an Hui Tian Blood Products Co., Ltd.-Company Report
|
January 2010 |
£495 |
XBiotech USA, Inc.-Company Report
|
January 2010 |
£495 |
WINTAC LIMITED-Company Report
|
January 2010 |
£495 |
Wellstat Vaccines, LLC-Company Report
|
January 2010 |
£495 |
Vitalis S.A. C.I.-Company Report
|
January 2010 |
£495 |
Vitabalans Oy-Company Report
|
January 2010 |
£495 |
Virostatics, srl-Company Report
|
January 2010 |
£495 |
Vivimed Labs Limited-Company Report
|
January 2010 |
£495 |
Vybion, Inc (formerly Viral Therapeutics, Inc.)-Company Report
|
January 2010 |
£495 |
Welichem Biotech Inc.-Company Report
|
January 2010 |
£495 |
Wampole Canada Inc.-Company Report
|
January 2010 |
£495 |
YM BioSciences Inc.-Company Report
|
January 2010 |
£495 |
Y's Therapeutics Co., Limited-Company Report
|
January 2010 |
£495 |
Zosano Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Zhejiang Jingxin Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Zhejiang Fengan Biopharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Zytras Life Sciences-Company Report
|
January 2010 |
£495 |
Biogen Idec: Pipeline - Products - Performance - Potential
|
January 2010 |
£595 |
Dainippon Sumitomo: Pipeline, Products, Performance, Potential
|
January 2010 |
£595 |
UCB: Pipeline - Products - Performance - Potential
|
January 2010 |
£595 |
Y's Therapeutics Co., Limited-Company Report
|
January 2010 |
£495 |
Xi'an Libang Pharmaceuticals Co., Ltd-Company Report
|
January 2010 |
£495 |
YuSheng Pharmaceutical Co.-Company Report
|
January 2010 |
£495 |
Yes Biotech Laboratories Ltd.-Company Report
|
January 2010 |
£495 |
Yaupon Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Yuyu Pharma, Inc.-Company Report
|
January 2010 |
£495 |
Zeon LifeSciences Limited-Company Report
|
January 2010 |
£495 |
Xi'an Hui Tian Blood Products Co., Ltd.-Company Report
|
January 2010 |
£495 |
Zhejiang Deyer Pharmaceutical Co., Ltd-Company Report
|
January 2010 |
£495 |
Versartis, Inc.-Company Report
|
January 2010 |
£495 |
Vernalis plc-Company Report
|
January 2010 |
£495 |
Torque Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Tianjin Zhongxin Pharmaceutical Group Co., Ltd-Company Report
|
January 2010 |
£495 |
Thrasos, Inc.-Company Report
|
January 2010 |
£495 |
Towa Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Tragara Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Transave, Inc.-Company Report
|
January 2010 |
£495 |
TransDermal Technologies, Inc.-Company Report
|
January 2010 |
£495 |
Thornton and Ross Limited-Company Report
|
January 2010 |
£495 |
TRAPHACO Joint Stock Company-Company Report
|
January 2010 |
£495 |
Tego Science, Inc.-Company Report
|
January 2010 |
£495 |
TechnoVax, Inc.-Company Report
|
January 2010 |
£495 |
TcL Pharma SAS-Company Report
|
January 2010 |
£495 |
Terumo Corp-Company Report
|
January 2010 |
£495 |
Teva-Tuteur-Company Report
|
January 2010 |
£495 |
Therametics, LLC.-Company Report
|
January 2010 |
£495 |
The Government Pharmaceutical Organization-Company Report
|
January 2010 |
£495 |
Transition Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Translational Research, Ltd.-Company Report
|
January 2010 |
£495 |
Validus Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Valentis-Company Report
|
January 2010 |
£495 |
Vaishnavi Lifescience Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
VaxInnate Corporation-Company Report
|
January 2010 |
£495 |
VectorLogics, Inc.-Company Report
|
January 2010 |
£495 |
Venkat Pharma Limited-Company Report
|
January 2010 |
£495 |
Vemedia B.V.-Company Report
|
January 2010 |
£495 |
United Pharmaceuticals-Company Report
|
January 2010 |
£495 |
United Laboratories Inc.-Company Report
|
January 2010 |
£495 |
Trius Therapeutics (formerly Rx3 Pharmaceuticals, Inc.)-Company Report
|
January 2010 |
£495 |
Trigen Pharma International-Company Report
|
January 2010 |
£495 |
Transport Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
UAS Laboratories-Company Report
|
January 2010 |
£495 |
UCB Japan Co., Ltd.-Company Report
|
January 2010 |
£495 |
Uni-Bio Science Group Ltd.-Company Report
|
January 2010 |
£495 |
UNI PHARMA-Company Report
|
January 2010 |
£495 |
Sagmel, Inc.-Company Report
|
January 2010 |
£495 |
SANAVITA ENTERPRISES, INC.-Company Report
|
January 2010 |
£495 |
Nihon Nohyaku Co Ltd-Company Report
|
January 2010 |
£495 |
Nigerian-German Chemicals Plc-Company Report
|
January 2010 |
£495 |
Newai Chemical Industrial Co. Ltd.-Company Report
|
January 2010 |
£495 |
Nippon Boehringer Ingelheim Co., Ltd.-Company Report
|
January 2010 |
£495 |
Nissui Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Nordic Bioscience a/s-Company Report
|
January 2010 |
£495 |
Nitto Denko Corporation-Company Report
|
January 2010 |
£495 |
NitroMed, Inc.-Company Report
|
January 2010 |
£495 |
New GPC Inc.-Company Report
|
January 2010 |
£495 |
Neurotech Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Neimeth International Pharmaceuticals PLC.-Company Report
|
January 2010 |
£495 |
NeED pharma-Company Report
|
January 2010 |
£495 |
Natren, Inc.-Company Report
|
January 2010 |
£495 |
NeoStrata Company, Inc.-Company Report
|
January 2010 |
£495 |
Neogenix Oncology Corporation-Company Report
|
January 2010 |
£495 |
Neumedicines Inc.-Company Report
|
January 2010 |
£495 |
Neopharm Ltd.-Company Report
|
January 2010 |
£495 |
Nordic Drugs AB-Company Report
|
January 2010 |
£495 |
Norma Hellas S.A.-Company Report
|
January 2010 |
£495 |
OPALIA Pharma-Company Report
|
January 2010 |
£495 |
NsGene A/S-Company Report
|
January 2010 |
£495 |
Novus Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
ORALANCE PHARMA-Company Report
|
January 2010 |
£495 |
Olainfarm-Company Report
|
January 2010 |
£495 |
Oncolytics Biotech Inc-Company Report
|
January 2010 |
£495 |
Oman Pharmaceutical Products Co. L.L.C.-Company Report
|
January 2010 |
£495 |
Novozymes A/S-Company Report
|
January 2010 |
£495 |
Novogen Limited-Company Report
|
January 2010 |
£495 |
NovaLead Pharma Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
NovImmune SA-Company Report
|
January 2010 |
£495 |
Northern Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Novartis Pharma K.K.-Company Report
|
January 2010 |
£495 |
Noven Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Novo Nordisk A/S-Company Report
|
January 2010 |
£495 |
Noventis s.r.o.-Company Report
|
January 2010 |
£495 |
Natrapharm Inc.-Company Report
|
January 2010 |
£495 |
National Enzyme Company-Company Report
|
January 2010 |
£495 |
Medpharma-Company Report
|
January 2010 |
£495 |
Medis laboratories-Company Report
|
January 2010 |
£495 |
Medipost Co., Ltd-Company Report
|
January 2010 |
£495 |
Meizler Biopharma S/A-Company Report
|
January 2010 |
£495 |
Meldex International Plc-Company Report
|
January 2010 |
£495 |
MicroDose Therapeutx, Inc. (formerly MicroDose Technologies, Inc.)-Company Report
|
January 2010 |
£495 |
MethylGene Inc-Company Report
|
January 2010 |
£495 |
Metabolic Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Medimetriks Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Medicure Inc.-Company Report
|
January 2010 |
£495 |
Medical Enzymes AG-Company Report
|
January 2010 |
£495 |
Medicago-Company Report
|
January 2010 |
£495 |
Medexus Inc.-Company Report
|
January 2010 |
£495 |
MedImmune, Inc. (formerly Cambridge Antibody Technology)-Company Report
|
January 2010 |
£495 |
Medical Futures Inc.-Company Report
|
January 2010 |
£495 |
Medicom International s.r.o.-Company Report
|
January 2010 |
£495 |
Medical Union Pharmaceuticals-Company Report
|
January 2010 |
£495 |
MOLOGEN AG-Company Report
|
January 2010 |
£495 |
M's Science Corporation-Company Report
|
January 2010 |
£495 |
NAL Pharmaceuticals Ltd-Company Report
|
January 2010 |
£495 |
Myriad Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Mymetics Corporation-Company Report
|
January 2010 |
£495 |
miRagen Therapeutics-Company Report
|
January 2010 |
£495 |
Nang Kuang Pharmaceutical Co., Ltd.-Company Report
|
January 2010 |
£495 |
Naprod Life Sciences Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
NanoCarrier Co., Ltd.-Company Report
|
January 2010 |
£495 |
Mylan New Zealand Limited (formerly Pacific Pharmaceuticals Ltd)-Company Report
|
January 2010 |
£495 |
Multicare Pharmaceuticals Philippines Inc.-Company Report
|
January 2010 |
£495 |
Mimetogen Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Migenix Inc-Company Report
|
January 2010 |
£495 |
Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co.-Company Report
|
January 2010 |
£495 |
Mithridion, Inc-Company Report
|
January 2010 |
£495 |
Miwana AB-Company Report
|
January 2010 |
£495 |
Mt Cook Pharma-Company Report
|
January 2010 |
£495 |
Morphotek Inc.-Company Report
|
January 2010 |
£495 |
Oncovir, Inc-Company Report
|
January 2010 |
£495 |
One Pharma Company Inc.-Company Report
|
January 2010 |
£495 |
Proge Farm S.r.l.-Company Report
|
January 2010 |
£495 |
Profectus BioSciences, Inc.-Company Report
|
January 2010 |
£495 |
ProNAi Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Progen Pharmaceuticals Ltd.-Company Report
|
January 2010 |
£495 |
Prollenium Medical Technologies Inc.-Company Report
|
January 2010 |
£495 |
Qualiphar NV-Company Report
|
January 2010 |
£495 |
PureTek Corporation-Company Report
|
January 2010 |
£495 |
Promed Group-Company Report
|
January 2010 |
£495 |
Prana Biotechnology Limited-Company Report
|
January 2010 |
£495 |
Portola Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Plus India-Company Report
|
January 2010 |
£495 |
Plantacor, Inc-Company Report
|
January 2010 |
£495 |
Piramal Life Sciences Limited-Company Report
|
January 2010 |
£495 |
PRB Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
PTC Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Polichem S.A.-Company Report
|
January 2010 |
£495 |
Polfa Warszawa S.A.-Company Report
|
January 2010 |
£495 |
Quintessence Biosciences, Inc.-Company Report
|
January 2010 |
£495 |
RESprotect GmbH-Company Report
|
January 2010 |
£495 |
ratiopharm GmbH-Company Report
|
January 2010 |
£495 |
Riva Pharma, S.A.E.-Company Report
|
January 2010 |
£495 |
Riso Pharma Tech (RISO)-Company Report
|
January 2010 |
£495 |
R-Tech Ueno, Ltd.-Company Report
|
January 2010 |
£495 |
Ronak Healthcare-Company Report
|
January 2010 |
£495 |
SAF FERMION LIMITED-Company Report
|
January 2010 |
£495 |
Ruyan Group (Holdings) Limited-Company Report
|
January 2010 |
£495 |
Rising Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Renata Limited-Company Report
|
January 2010 |
£495 |
Raptakos, Brett & Co.Ltd.-Company Report
|
January 2010 |
£495 |
Radiance Pharmaceutical (India) Private Limited-Company Report
|
January 2010 |
£495 |
RHEI Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Razak Laboratories Co.-Company Report
|
January 2010 |
£495 |
ReGen Therapeutics Plc-Company Report
|
January 2010 |
£495 |
Remington Pharmaceutical Industries (Pvt.) Ltd-Company Report
|
January 2010 |
£495 |
Reig Jofre Group-Company Report
|
January 2010 |
£495 |
Pico Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Phytopharm Plc-Company Report
|
January 2010 |
£495 |
Parenteral Drug India Ltd.-Company Report
|
January 2010 |
£495 |
PanTheryx, Inc.-Company Report
|
January 2010 |
£495 |
PD Pharmaceuticals-Company Report
|
January 2010 |
£495 |
Parggon Laboratories Inc.-Company Report
|
January 2010 |
£495 |
Paviour Pharmaceuticals Pvt Ltd.-Company Report
|
January 2010 |
£495 |
Pepscan Holdings-Company Report
|
January 2010 |
£495 |
Pentech Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Ozone Laboratories SRL-Company Report
|
January 2010 |
£495 |
Oy Verman Ab-Company Report
|
January 2010 |
£495 |
Orbus Pharma Inc-Company Report
|
January 2010 |
£495 |
Opsona Therapeutics-Company Report
|
January 2010 |
£495 |
OphthalmoPharma Ltd.-Company Report
|
January 2010 |
£495 |
Orchid Chemicals & Pharmaceuticals Limited-Company Report
|
January 2010 |
£495 |
Ortho Dermatologics (formerly Orthoneutrogena)-Company Report
|
January 2010 |
£495 |
Oscotec Inc.-Company Report
|
January 2010 |
£495 |
Oryzon genomics-Company Report
|
January 2010 |
£495 |
Pfizer Japan Inc.-Company Report
|
January 2010 |
£495 |
Phage Biotechnology Corp-Company Report
|
January 2010 |
£495 |
Phenomix Corporation-Company Report
|
January 2010 |
£495 |
Phebra-Company Report
|
January 2010 |
£495 |
Pharming Group NV-Company Report
|
January 2010 |
£495 |
Phico Therapeutics Ltd.-Company Report
|
January 2010 |
£495 |
Phosphagenics Limited-Company Report
|
January 2010 |
£495 |
Phytohealth Corporation-Company Report
|
January 2010 |
£495 |
Physica Pharma-Company Report
|
January 2010 |
£495 |
Pharmaxis Ltd-Company Report
|
January 2010 |
£495 |
Pharmatex Italia Srl-Company Report
|
January 2010 |
£495 |
Pharma Dynamics-Company Report
|
January 2010 |
£495 |
PharmEvo (Pvt.) Ltd.-Company Report
|
January 2010 |
£495 |
PHARMA INTERNATIONAL CO.-Company Report
|
January 2010 |
£495 |
Pharma Nord ApS-Company Report
|
January 2010 |
£495 |
PharmaBrand S.A.-Company Report
|
January 2010 |
£495 |
Pharmatec Pakistan (private) Limited-Company Report
|
January 2010 |
£495 |
PharmaGap Inc.-Company Report
|
January 2010 |
£495 |
BioCis Pharma Ltd.-Company Report
|
January 2010 |
£495 |
BioArctic Neuroscience AB-Company Report
|
January 2010 |
£495 |
Asia Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
Ascenta Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Ascent Pharmahealth Limited (formerly Genepharm Australasia Limited)-Company Report
|
January 2010 |
£495 |
Asterion Ltd-Company Report
|
January 2010 |
£495 |
Astex Therapeutics-Company Report
|
January 2010 |
£495 |
Atley Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Atlantic Healthcare Limited-Company Report
|
January 2010 |
£495 |
Astion Pharma A/S-Company Report
|
January 2010 |
£495 |
Ascend Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Asahi Kasei Corporation-Company Report
|
January 2010 |
£495 |
Arpida Ltd.-Company Report
|
January 2010 |
£495 |
ArmaGen Technologies, Inc.-Company Report
|
January 2010 |
£495 |
Ark Therapeutics Group plc-Company Report
|
January 2010 |
£495 |
Arriva Pharmaceuticals, Inc-Company Report
|
January 2010 |
£495 |
Arrow Generics Ltd-Company Report
|
January 2010 |
£495 |
Arvind Remedies Ltd-Company Report
|
January 2010 |
£495 |
Arteriocyte Medical Systems, Inc.-Company Report
|
January 2010 |
£495 |
AtralCipan-Company Report
|
January 2010 |
£495 |
Attenuon, LLC-Company Report
|
January 2010 |
£495 |
Azur Pharma Limited-Company Report
|
January 2010 |
£495 |
Axcan Pharma Inc.-Company Report
|
January 2010 |
£495 |
Avontec GmbH-Company Report
|
January 2010 |
£495 |
B. Braun Melsungen AG-Company Report
|
January 2010 |
£495 |
B.F. Ascher & Co. Inc.-Company Report
|
January 2010 |
£495 |
BARAKAT Pharmaceutical Industries-Company Report
|
January 2010 |
£495 |
BAL PHARMA LTD.-Company Report
|
January 2010 |
£495 |
Avir Green Hills Biotechnology AG-Company Report
|
January 2010 |
£495 |
Avineuro Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Avanti Therapeutics-Company Report
|
January 2010 |
£495 |
Aurora Pharmaceuticals Pty Ltd.-Company Report
|
January 2010 |
£495 |
Aurobindo Pharma Ltd.-Company Report
|
January 2010 |
£495 |
Avera Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Avexa Limited-Company Report
|
January 2010 |
£495 |
Avila Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Avidas Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Arisyn Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Aristopharma Ltd.-Company Report
|
January 2010 |
£495 |
Angion Biomedica Corp.-Company Report
|
January 2010 |
£495 |
Angioblast Systems, Inc.-Company Report
|
January 2010 |
£495 |
AngioLab, Inc.-Company Report
|
January 2010 |
£495 |
Anglo-French Drugs & Industries Ltd.-Company Report
|
January 2010 |
£495 |
Antibe Therapeutics Inc.-Company Report
|
January 2010 |
£495 |
Antisense Therapeutics Limited-Company Report
|
January 2010 |
£495 |
Antisense Pharma GmbH-Company Report
|
January 2010 |
£495 |
Antipodean Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
AngioChem Inc.-Company Report
|
January 2010 |
£495 |
Angelini-Company Report
|
January 2010 |
£495 |
Amulet Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
AmpliMed Corporation-Company Report
|
January 2010 |
£495 |
Amphastar Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Amura Holdings Ltd.-Company Report
|
January 2010 |
£495 |
AnGes MG, Inc.-Company Report
|
January 2010 |
£495 |
AndroScience Corporation-Company Report
|
January 2010 |
£495 |
Anacor Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Antyra, Inc.-Company Report
|
January 2010 |
£495 |
Anza Therapeutics, Inc.-Company Report
|
January 2010 |
£495 |
Argenta Discovery Ltd.-Company Report
|
January 2010 |
£495 |
Archimedes Pharma Limited-Company Report
|
January 2010 |
£495 |
Archer Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Argos Therapeutics, Inc., (formerly Merix Bioscience)-Company Report
|
January 2010 |
£495 |
Aridis Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Aristo Pharmaceuticals Pvt. Ltd.-Company Report
|
January 2010 |
£495 |
Arisaph Pharmaceuticals, Inc.-Company Report
|
January 2010 |
£495 |
Archemix Corp.-Company Report
|
January 2010 |
£495 |
Aquinox Pharmaceuticals Inc.-Company Report
|
January 2010 |
£495 |
Apitope Technology (Bristol) Ltd-Company Report
|
January 2010 |
£495 |
Apipol-Farma Ltd-Company Report
|
January 2010 |
£495 |
Aphios Corporation-Company Report
|
January 2010 |
£495 |
Apogenix GmbH-Company Report
|
January 2010 |
£495 |
ApopLogic Pharmaceuticals, LLC-Company Report
|
January 2010 |
£495 |
Applied Genetic Technologies Corporation (AGTC)-Company Report
|
January 2010 |
£495 |
Apotex Inc.-Company Report
|
January 2010 |
£495 |
BCN Plc-Company Report
|
January 2010 |
£495 |
Bakhtar Bioshimi Co.-Company Report
|
January 2010 |
£495 |
Matrixx Initiatives Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Marshall Edwards Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Mannatech Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Medarex Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
MediciNova Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Medivation Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Medistem, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Medicis Pharmaceutical Corp-Detailed Product Pipeline
|
January 2010 |
£495 |
MannKind Corp-Detailed Product Pipeline
|
January 2010 |
£495 |
Manhattan Pharmaceuticals Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Xenoport Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
XTL Biopharmaceuticals Ltd-Detailed Product Pipeline
|
January 2010 |
£495 |
XOMA Ltd-Detailed Product Pipeline
|
January 2010 |
£495 |
ZIOPHARM Oncology Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
ZymoGenetics, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
MDRNA, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Ardea Biosciences, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Merck & Co Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
MicroIslet, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Neurobiological Technologies Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Neuro-Hitech Pharmaceuticals Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
NeoPharm Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Neurocrine Biosciences Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
Neurogen Corporation-Detailed Product Pipeline
|
January 2010 |
£495 |
NeurogesX, Inc.-Detailed Product Pipeline
|
January 2010 |
£495 |
Neurogenesis Inc-Detailed Product Pipeline
|
January 2010 |
£495 |
|
|
